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Abstract
The aim of this study was to examine the causes of sensorineural hearing loss in the 
Bangladeshi population resident in East London. Almost all of this population originates 
from Sylhet, a province in Bangladesh. The study was conducted at a community based 
audiology clinic and tertiary level genetics department. One hundred and fifteen families 
(134 patients) were ascertained; 11 families declined to participate and 4 families could 
not be contacted. All children of Bangladeshi ethnic origin with bilateral sensorineural 
hearing loss more than 40dB in the better hearing ear were included in this study. 
Information on all these patients was collected from their case notes. For the 67 patients 
in whom the cause of deafness was not clear from the records or unknown (or non- 
syndromic deafness), families were seen in the research clinic.
The prevalence of deafness >40db in Bangladeshi children under 16 years of age 
in East London was calculated to be approximately 3.86 per 1000 (95%CI: 3.24, 4.47). 
This is nearly 2.3 times the national average. Parents were consanguineous in 35 out of 
105 families (33.3%) in which this information was available. On calculating the 
prevalence of deafness in the Bangladeshi children belonging to non-consanguineous 
families, the prevalence falls to 2.72 per 1000 (95%CI: 2.10, 3.34). Genetic causes appear 
to be the most common cause of deafness in Bangladeshi population in 59.6% patients. 
Environmental causes were responsible for hearing loss in 18.5% patients and in 21.8% 
cases the cause of deafness was undetermined. Of the deafness due to genetic causes, 
57.7% were non-syndromic, 25.3% syndromic and 16.9% were chromosomal.
The single most common cause of sensorineural hearing loss in the Bangladeshi 
population in this study was due to mutations in the GJB2 gene (Connexin 26) in 14 of
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these families. The mutations in GJB2 in this population were W24X, IVS1 + 1G->A, 
M 1V, V95M and W77X. W24X was the most common mutation seen in 40% (8/20) 
patients. Genetic causes are the common cause of deafness in subjects of Bangladeshi 
origin and 29.8% children with non-syndromic deafness were positive for mutations in 
GJB2.
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Definitions
The terminology used in this thesis (Fortnum et al. 2001):
Congenital impairment: Hearing loss that is recognized at birth or believed to have
been present since birth.
Late onset impairment: Hearing loss that first manifests itself after birth and cannot
be attributed to an identifiable exogenous cause.
Progressive impairment: Deterioration in hearing greater than or equal to 15dB in the
pure tone average within a ten year period.
Acquired impairment: Hearing loss that first manifests after birth and can be
attributed to an identifiable exogenous cause.
Confirmation of
hearing impairment:
Ascertainment:
This is the outcome of the process of establishing that a child 
has hearing loss.
The identification of a child from one or more notifications by 
the research team.
Total ascertainment: This is the process of attempting to ascertain all cases in the
population.
Prevalence of hearing loss: The number of children per thousand live births in an annual
birth cohort with confirmed permanent bilateral hearing loss.
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The definitions used for different types of hearing loss are (Davis & Mencher 2002)
Sensorineural: Hearing loss due to disease or deformity of the inner ear or
cochlear nerve with an air bone gap of less than 15dB averaged 
over 0.5,1 and 2 KHz.
Conductive: Hearing loss due to disease or deformity of the external or
middle ear with an air bone gap of more than 15dB and normal 
bone conduction (<20dB) averaged over 0.5,1 and 2 KHz.
Mixed: Hearing loss due to combined involvement of middle or external
ear and inner ear or cochlear nerve. The audiogram shows bone 
conduction thresholds greater than 20dB and air bone gap more 
than 15dB averaged over 0.5,1 and 2 KHz.
Sensory: This is a subdivision of sensorineural hearing loss due to disease
or deformity in the cochlea.
Neural: This is a subdivision of sensorineural hearing loss due to disease
or deformity in the cochlear nerve.
Central: This is a sensorineural hearing loss due to disease or deformity
in the central nervous system cephalic to the cochlear nerve.
Average hearing level: This is an average of the level of hearing thresholds measured in
the better hearing ear at 0.5,1,2 and 4 KHz.
Mild hearing loss: An average hearing level of between 20-39dB (Stephens 2001).
Moderate hearing loss: An average hearing level of between 40-69dB (Stephens 2001).
Severe: An average hearing level of between 70-94dB (Stephens 2001).
Profound: An average hearing level of more than 95dB (Stephens 2001).
13
Asymmetrical hearing loss: This refers to a greater than lOdB difference between the
ears in at least two frequencies with the average hearing 
threshold more than 20dB in the better hearing ear.
Low frequency ascending: More than or equal tol 5dB between poorer low frequency
thresholds and high frequencies.
Mid frequency loss: More than or equal to 15 dB between poorest mid frequency
thresholds and low and high frequencies.
Less thanl5dB difference between mean of 250/500 Hz, 
mean of 1 & 2 kHz and the mean of 4 and 8 kHz thresholds. 
15-29dB difference between 500-1000Hz mean and 4000- 
8000Hz mean.
More than or equal to 30dB difference between 500-1000Hz 
mean and 4000-8000Hz mean.
Progressive hearing loss: More than or equal to 15dB deterioration over a 10 year
period in the average of 0.5, 1, 2 and 4 KHz frequencies.
Loci for genes are defined as:
DFNA Autosomal recessive
DFNB Autosomai dominant
DFN X linked
Flat loss:
Gently sloping:
Steeply sloping:
14
1 Introduction
Effect of hearing on language & social development
Hearing impairment has a big impact on the development of language and 
communication. It can lead to poor literacy skills (Davis & Mencher 2002) and poor 
verbal communication (Powers 1996) which can have a detrimental effect on 
employment opportunities in the long term (Davis & Mencher 2002). A study of 344 deaf 
pupils concluded that the severity of deafness was closely related to speech 
communication ability and social integration with hearing friends (Powers 1996). In view 
of the effect that deafness can have on children and their families, it is important to have 
information about prevalence and aetiology in the population.
The older the child when a congenital hearing loss is diagnosed, the greater are the 
chances of severe delay in language development (McFarland & Simmons 1980). The 
most important period for language development of a child is from birth to the age of 2.5 
years (Moore et al. 1991 ,Egeli et al. 2003). Thus it has been believed for long time that 
earlier identification of hearing impairment must lead to better outcomes, and there is 
now reliable evidence that this is the case for communication development, educational 
achievement and quality of life (Robinshaw 1995,Yoshinaga-Itano et al. 2000,Moeller 
2000). In a study of 112 children with deafness who were enrolled in a comprehensive 
intervention programme, vocabulary skills at 5 years were evaluated (Moeller 2000). A 
significant negative correlation was found between age of intervention and language 
development at 5 years. Children with earliest intervention (11 months) had significantly
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better vocabulary than children with late intervention. Also in this study children with 
early intervention scored as well as the hearing children regardless of the severity of 
deafness. In a longitudinal study (Robinshaw 1995), 5 children with severe to profound 
deafness who had been wearing hearing aids from 3 to 6 months of age were studied up 
to 21 months of age. The authors concluded that children using hearing aids by 6 months 
of age acquired vocal communication and language skills at an age comparable with their 
normal hearing counterparts. This study also emphasised that reduced auditory 
stimulation for periods of only 3 to 6 months could delay the normal course of language 
acquisition. In another study (Yoshinaga-Itano et al. 2000), 50 children (25 matched pairs 
bom in hospitals with and without newborn hearing screening) with deafness were 
analysed with regards to their speech and language development. It was found that 
children bom in hospitals which had newborn hearing screening performed much better 
in both language and vocabulary than those who were bom in hospitals that did not. Most 
authors agree that early identification and rehabilitation is better.
Methods of early detection of hearing loss
However, in spite of this evidence, even until quite recently, the mean age of detection of 
hearing impairment was about 24 to 33 months according to a number of published 
studies (Samo & Clemis 1980,Newton 1985,Naarden et al. 1999). In the study of 111 
children in UK the mean age at diagnosis of hearing loss was 23.5 months (Newton 
1985). In the US the mean age of confirmation of hearing loss was reported as 28 months
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(Samo & Clemis 1980), and 33 months in another study off 173 children (Naarden et al.
1999).
Various screening and surveillance programmes have been introduced in order to try to 
reduce the age of identification of hearing impairment i.e. the health visitor distraction 
test (Haggard et al. 1992,McCormick 1993) and the targeted and universal neonatal 
screening (Stevens et al. 1991,Watkin 1996). The age of identification via the health 
visitor distraction test varied from 12 to 20 months.with poor sensitivity and specificity 
(Davis et al. 1997). Protocols for screening newborns for hearing impairment, which 
were based on specified high risk criteria, usually identified only about half of all infants 
with congenital hearing loss.
Three key factors were included as criteria for targeting children (Stevens & Parker 
2002):
• History of admission to Neonatal Intensive care unit for more than 48 hours
• Family history of early childhood deafness
• Syndrome associated with hearing impairment
It was estimated that 50% of all children with bilateral hearing impairment >50db had 
one or more of these three factors.
However it was proposed that Neonatal screening using otoacoustic emissions has higher 
sensitivity and higher specificity compared with other methods for hearing screening. 
Otoacoustic emissions (OAE) originate in the cochlea and are due to the biomechanical 
process associated with normal hearing. OAEs can be recorded only when a region of
17
normal cochlear function is present and their absence could be due to presence of outer or 
middle ear disease or poor recording conditions or cochlear deafness. OAEs are recorded 
by a probe placed in the ear canal which has a loudspeaker to generate the sound stimulus 
and a microphone to record the sound in the ear canal. OAEs are classified into Transient 
evoked otoacoustic emission (TEOAE) and Distortion product otoacoustic emission 
(DPOAE). TEOAE is a response to a short transient sound. For DPOAE two sound 
stimuli at different frequencies are delivered. OAEs are not normally present when the 
hearing loss is more than 30dB (Stevens & Parker 2002).
Universal Neonatal Hearing Screening (now called Newborn Hearing Screening (Davis et 
al. 1997)) has now been introduced throughout UK (Davis et al. 2001b,NHS Executive 
2004) because of its potential to reduce the age of confirmation of hearing loss (Dalzell et 
al. 2000). Data from the screening and assessments is kept nationally on a database 
integrated with other child services. This will help in monitoring the development of 
hearing loss at a later date and also to look at the effectiveness of the screening 
programme. The universal programmes implemented have given yield of expected 
prevalence (1-1.3 per 1000), with a median identification age for the children screened of 
about 2 months (Davis et al. 1997).
Screening for hearing loss in newborns has been shown to be cost effective and efficient 
(Stevens et al. 1998,Davis et al. 2001a). It has been reported to have a sensitivity of 80- 
90%, false positive rate of less than 2% (Yoshinaga-Itano et al. 2000,Kennedy et al.
2000) and a positive predictive value of 17%. The proposed costs of such screening in the 
United Kingdom are much lower than costs of the previous infant distraction screen test
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(Pressman et al. 1999). It was recommended by Davis et al that a programme based on 
universal neonatal screening followed at 7 months by a targeted screen using an infant 
distraction test is a good option for picking up children with deafness early (Davis et al. 
1997).
1.1 H earing Impairment
1.1.1 Epidemiology of Hearing Impairment
Epidemiological information can be used to plan and evaluate strategies to prevent 
morbidity and to effectively manage those in whom a disorder has already developed and 
the same can be said for hearing loss.
A number of studies have estimated the prevalence rates of permanent hearing 
impairment in children to be 1 to 2 per 1000 live births (Maki-Torkko et al.
1998,Naarden et al. 1999,Uus & Davis 2000,Fortnum et al. 2001,Fortnum 2003). The 
range of severity is wide and for an individual may fluctuate over time. Severity may not 
be symmetrical for the two ears. The hearing impairment may develop progressively over 
time or it may be worsened temporarily by other causes (Fortnum 2003).
In a nationwide study, Fortnum et al ascertained 17,160 children from all the postcode 
areas in UK (Fortnum et al. 2001). It was concluded that the prevalence of confirmed 
childhood deafness increases up to the age of 9 years to a level higher than estimated 
previously. In practical terms, for 1 hearing impaired per 1000 live births recognised by 
neonatal hearing screening, 50-90% more children are diagnosed with deafness by 9 
years of age. This study was large and covered entire UK. As a result of the
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comprehensive ascertainment of their cases, prevalence figures from this study (Fortnum 
et al. 2001) have been used for comparison with the data in this thesis.
1.1.2 Causes of Deafness
• Knowing the causes of deafness is important as it provides a more logical
approach to management of these children and may help to organize preventive 
measures in the future (Janzen & Schaefer 1984).
For this study we have classified the causes of deafness into genetic, acquired and 
unknown. However, ascribing the cause to one of these categories is not always 
straightforward. The study examining the causes of hearing loss in children in Greater 
Manchester has highlighted the problems in establishing the cause of hearing loss in a 
child (Newton 1985). There can be multiple coexisting factors causing deafness in 
children. Late diagnosis of hearing loss reduces the chances of confirming hearing loss 
which is due to intrauterine causes and in spite of the difficulties, the clinician is expected 
to reach some conclusion regarding the cause of deafness.
It is estimated that approximately 50% of prelingual hearing loss is caused by genetic 
factors (Marazita et al. 1993), 25% are due to environmental factors (prematurity, 
infections, trauma and ototoxicity) and the cause is unknown in the rest 25% of cases. 
Even in the unknown group, most of the causes are assumed to be genetic in origin. 
Genetic causes account for the largest proportion of cases of prelingual hearing loss 
(Schrijver 2004).
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The main causes of acquired/environmental hearing loss are pre or post-natal acquired 
infections, pre or post-natal drug therapy and other perinatal factors like prematurity, 
hypoxia, hyperbilirubinemia, neonatal sepsis and low birth weight. Infections acquired in 
the pre-natal period that can cause sensorineural hearing loss include rubella (Martin et 
al. 1981,Newton 1985,Parving & Hauch 1994), toxoplasmosis and cytomegalovirus 
(Newton 1985,Davis & Mencher 2002). The most common post-natal infection causing 
hearing loss is meningitis (Davis et al. 1995,Davis & Mencher 2002).
1.1.3 Aetiological Investigations
Investigations to determine the aetiology of deafness start with a detailed prenatal, 
medical and family history. Risk factors for the hearing loss such as low birth weight, 
prematurity, low APGAR scores, admission to neonatal ICU and jaundice should be 
assessed. This should be followed by a detailed clinical examination to exclude features 
compatible with a syndrome or congenital infections (in neonates).
Specifically an ophthalmologic assessment should be requested. Ocular abnormalities 
such as cataract, retinal pigmentation and optic atrophy can be present in children with 
severe to profound hearing loss and their diagnosis may help in determining aetiology as 
well as being important for the child’s management (Armitage et al. 1995).
Laboratory testing should be individualized and directed towards the suspected diagnosis. 
The tests may include IgM antibody assay in first weeks of life to rule out the possibility
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of intrauterine infections, urine analysis in patients with possible Alport syndrome, 
thyroid function tests and Perchlorate test in suspected Pendred syndrome and evaluation 
of metabolic disorders (Hone & Smith 2002). An ECG should be done to assess the cQT 
interval if Jervell Lange Nielsen syndrome is suspected.
Patients with unexplained hearing loss should have a renal ultrasound and temporal bone 
imaging. Imaging should include a high resolution CT scan to assess the bony structures 
(presence of malformations of the labyrinth) or MRI to assess the acoustic nerve and the 
inner ear.
Genetic testing which currently involves analysis for GJB2 mutations, should be offered 
to any child with permanent bilateral non-syndromic hearing loss of any severity as it is a 
common cause of recessive hearing loss in most of the populations (Bitner-Glindzicz 
2002). Moreover it requires a simple blood sample and the screening is straightforward 
and economical. Less invasive samples such as buccal cells obtained with a swab or part 
of the blood spots used for newborn screening could also be used.
Preciado et al recommended that a sequential testing approach to determine aetiology 
would be more appropriate and more cost effective than the commonly followed 
simultaneous approach (Preciado et al. 2004). In their algorithm, all patients with hearing 
loss should first undergo detailed case history review, physical examination and a 
complete audiologic review. When the aetiology is not determined, patients with bilateral 
sensorineural hearing loss should first undergo GJB2 screening. If no abnormality is
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found on screening, then imaging is performed. Laboratory testing should be ordered 
only when mandated by clinical findings. When bilateral hearing loss is severe, ECG 
testing is indicated. In patients with unilateral hearing loss, only temporal bone imaging 
is required and GJB2 screening and laboratory testing is not required. Ophthalmologic 
evaluation should be carried out in all children with sensorineural hearing loss to rule out 
a coexisting sensory impediment. In children with bilateral profound hearing loss and 
normal genetic testing and imaging, electroretinography can be a valuable diagnostic tool 
for Type 1 Usher’s syndrome (type 1 Usher causes profound HL and vestibular failure so 
can just do ERG in those with profound HL and delayed motor milestones).
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Figure 1: Algorithm for evaluation & management of sensorineural hearing loss in 
children(Preciado et aL 2004)
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1.2 Genes causing deafness
1.2.1 Genes
Genes consist of coding sequences (exons), interrupted by non-coding sequences 
(introns). However the coding sequences in the human genome comprise only 2-3% of all 
the DNA in the cell nucleus and the remainder is non-coding DNA (Read 1996)
Genes, in particular the coding region of DNA, specify the sequence of amino acids in a 
particular protein. DNA consists of four bases, Arginine, Thymine, Cytosine and Guanine 
and every three (a codon) in a coding region, specify a particular amino acid. They are 
transcribed (synthesis of an RNA molecule containing the genetic message) from the 
DNA template, and then translated (synthesis of a polypeptide chain as per instructions in 
the genetic code of mRNA) by cellular ribosomes.
Mutations in a gene can cause a disease because either the mutated gene may lose its 
function and do nothing, or it may gain a harmful function. Mutations that result in loss 
of function normally cause recessive phenotypes, because usually cells can function on 
half the dose of the gene product. Sometimes they can cause dominant disease if the cells 
cannot function on half the product.
Genes may be mutated in a variety of ways. For example, deletion mutations result in 
deletion of part of, or the entire gene; within a coding sequence of DNA, single base 
substitutions may replace a codon for an amino acid with one for a stop codon (Nonsense 
mutation) or may result in one amino acid being replaced by another (Missense 
mutation); splice site mutations create or destroy signals for exon-intron splicing;
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ffameshift mutations are small insertions, deletions or splicing errors that change the way 
the continuous mRNA strand is read in triplet codons (Stracan & Read 1999). 
Polymorphisms are non-disease causing mutations which occur usually with prevalence 
greater than 1-2% in a normal population.
Mutations may be described in two ways. One is to describe the amino acid substitution 
i.e. V95M, which means that Valine at position 95 of the protein has been replaced with 
Methionine. The second method is to describe the DNA change i.e. 35delG, which means 
deletion of a single guanine at nucleotide number 35 of the gene.
Deletions of the whole gene, nonsense mutations and ffameshifts almost certainly destroy 
the gene function and are unlikely to result in protein production. A missense mutation 
may or may not be pathogenic according to whether it affects a part of the protein which 
is functionally important. Amino acid substitutions are more likely to affect function if 
they are very different (acidic by a basic amino acid or amino acids of different sizes). A 
sequence change in a disease gene that is present in an affected patient and not in the 
unaffected parents is very likely to be pathogenic and is called de novo mutation 
(Strachan & Read 1999).
1.2.2 Genetic hearing impairment
Of the hearing losses attributable to genetic causes, approximately 70% are classified as 
non-syndromic and 30% as syndromic (Gorlin et al. 1995). Non-syndromic deafness is 
not associated with other physical features. On the other hand, syndromic deafness is 
characterised by features involving other systems running together with hearing loss, for 
example retinitis pigmentosa in Usher syndrome, craniofacial dysmorphism in Treacher
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Collins syndrome, goitre in Pendred syndrome, long QT interval in Jervell and Lange- 
Nielsen syndrome and nephritis in Alport syndrome. In syndromic hearing loss it is 
important to make a correct diagnosis so as to monitor the individual and family for 
known complications of that syndrome. It is also important for genetic counselling that a 
correct diagnosis is made clinically or on molecular testing.
Non-syndromic hearing impairment can be further subdivided by the mode of 
inheritance. In the majority of the non-syndromic cases, approximately 80% show 
autosomal recessive inheritance, 20% are autosomal dominant, 1% are X linked and <1% 
are due to mitochondrial mutations (Morton 1991). Most non-syndromic autosomal 
recessive hearing impairment causes a prelingual hearing loss, which is usually severe to 
profound and not associated with any abnormal radiological findings. The dominant 
hearing loss is much more variable. Most non-syndromic autosomal dominant hearing 
loss is post lingual in onset and usually begins before 20 years of age, but it can be earlier 
ie. prelingual or can be much later in onset.
Remarkable progress has been made in the identification of the molecular basis of 
hearing loss in the past decade. To date 133 loci have been reported for non-syndromic 
hearing loss (54-autosomal dominant, 68-autosomal recessive, 8-X linked, 2-modifier 
loci and 1-Y linked locus). Of these loci, 45 of the genes for non-syndromic deafness 
have been identified and characterized (23-autosomal recessive, 21-autosomal dominant, 
1-X linked) (http: & webhost.ua.ac.be/hhh 2005). These genes encode a wide variety of 
molecules including structural proteins eg motor proteins (MY07A, MY06, MYOJ5), ion
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channels (KCNQ1, KCNQ4), transporters (SLC26A4) and gap junction proteins (GJB2,
GJB6).
Table 1: Autosomal Recessive genes identified to date (Adapted from Hereditary 
hearing loss homepage (http://nebhost.ua.ac.be/hhh)
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Table 2: Autosomal Dominant genes identified to date (Adapted from Hereditary 
hearing loss homepage (http://wchhost.ua.ac.be/hhh)
Table 3:X linked genes identified to date (Adapted from Hereditary hearing loss 
homepage (http://wcbhost.ua.ac.bc/hhh)
However mutations in the gap junction gene, GJB2, encoding the Connexin26 protein are 
the most common cause of genetic deafness. They have been shown to account for a 
significant proportion of recessive non-syndromic deafness in most populations studied, 
and account for almost 50% of clearly recessive cases in Western and Southern Europe 
and between 10% and 37% o f ‘sporadic’ cases (Estivill et al. 1998,Lench et al. 1998).
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1.3 M olecular architecture o f  Inner Ear
The inner ear is the sensory organ for hearing and balance. It consists of the bony and 
membranous labyrinths. The bony labyrinth is divided into the vestibule, cochlea and 
semicircular canals (Figure 2). The fluid inside the bony labyrinth is perilymph which has 
high Na+and low K+ concentration (like extracellular fluid) and inside the membranous 
labyrinth is endolymph, which has high concentration of K+ and low Na+. The border 
between these fluids is at the level of epithelial cells that surround the endolymphatic 
spaces. It is essential to maintain the permeability of this barrier for the inner ear 
function. The endolymphatic compartment is surrounded by three types of epithelium: 
sensory epithelium, ion transporting epithelium and relatively unspecialised epithelia 
(Forge & Wright 2002).
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Figure 2: Section of Inner Ear (Adapted from pages.cpsc.ucalgary.ca)
The sensory epithelium of the cochlea is the organ of Corti and that of the vestibular 
system are the maculae of the utricle and saccule and cristae of the semicircular canals. 
The sensory epithelium is composed of sensory hair cells and supporting cells (Figure 3). 
It is covered by the tectorial membrane in the cochlea, the otolithic membranes of the 
macular organs and the cupulae of the cristae. Hair cells are transducers converting a 
mechanical stimulus into an electric signal. Deflection of the hair cells caused by either 
sound waves (cochlea) or changes in head position (vestibule) modulates the flow of K+ 
from endolymph through the hair cells and that excites the hair cell activity.
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Figure 3: Section of Organ of Corti (Adapted from ourworId.compuserve.com)
The stria vascularis of the cochlea and the dark cell regions of the vestibular system are 
responsible for the ion transport necessary to maintain the endolymph composition.
The other less specialised epithelia, Reissner’s membrane in the cochlea and the 
epithelium of the roof the saccule, utricle and ampullae of the semicircular canals also 
form barriers separating the fluid spaces.
1.3.1 Hair cells
The hair bundle consists of rows of stereocilia and a single kinocilium located behind the 
row of longest stereocilia (Figure 4). Stereocilia consist of a core consisting of the 
cytoskeletal protein, actin, which is arranged in parallel bundles cross linked by fimbrin 
(Flock et a l 1982) and espin (Zheng et al 2000).The espin gene is mutated in the Jerker 
mice, who are deaf and show vestibular disorder (Zheng et al 2000). This shows the
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importance of actin bundling and maintenance of stereociliary rigidity for hair cell 
function.
Figure 4: Structure of Hair cells (Adapted from vestibular.wustl.edu)
The cuticular plate is a platform that supports the stereocilia, and consists of a meshwork 
of actin filaments. Some actin filaments descend from the stereocilia into the cuticular 
plate as a rootlet and crosslink with the actin meshwork. The cuticular plate also contains 
spectrin (Yilkosky et al. 1992), which cross links between actin filaments and 
tropomyosin, which binds around actin (Forge & Wright 2002). Various members of the 
myosin family of motor proteins, types lc, 6, 7a and 15 are also localised in the cuticular 
plate and stereocilia (Figure 5). Mutations in genes for different myosins cause hearing 
loss in humans (MY06, MY07A, MY015). Experimentally it has been proven that those
33
Figure 5: Stereocilia showing Myosin distribution (Adapted from www.bms.ed.ac.uk)
genes for myosins 6, 7a or 15 all have hearing loss, balance disorders and abnormalities 
in the stereociliary bundles (Steel & Kros 2001). In the Snell’s Waltzer mouse mutant 
where myosin 6 is defective, stereocilia are fused and greatly lengthened (Self et al.
1999). In the Shaker 2 mice with myosin 15 mutation, stereocilia are greatly reduced in 
height (Probst et al. 1998). In Shaker 1 mice with myosin 7a gene mutations, the 
stereocilia are separated (ie. splayed) apart from each other.
There are three different types of lateral links between stereocilia. The lateral links may 
play a role in holding the bundle of stereocilia together to stabilise it. These lateral links
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may be composed of protein, cadherin 23. Mutations in cadherin genes can cause hearing 
loss and balance disorders. In Usher syndrome type IF the protocadherin Pcdh 15 is 
defective, which is also seen in Ames Waltzer mouse mutant. In Usher syndrome type ID 
in humans and some non-syndromic deafhess, cadherin 23 is defective, which is also 
defective in Waltzer mouse strain. These proteins may form complexes that maintain the 
lateral tension between stereocilia (Figure 6).
Figure 6: Stereocilia showing tiplinks (Adapted from www.ks.iuc.edu>
Supporting cells provide mechanical support to the epithelium and the hair cells. These 
supporting cells contain the p form of actin, intermediate filaments, different isotypes of 
cytokeratins (Kuijpers et al 1991) and vimentin (Schulte & Adams 1989,Kuijpers et al. 
1991).
1.3.2 Potassium recycling in the cochlea
In the cochlea, the stereocilia are surrounded by the endolymph, which has high 
potassium concentration. When stereocilia are deflected, K+ ions from the endolymph 
flow through the channels in hair cells and result in depolarisation. As a result of this 
depolarisation the inner hair cells release neurotransmitter at synaptic junctions with the
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afferent neurons. The outer hair cells fine tune the response to sound frequencies. The 
recycling of the K+ ions (Figure 7) from the depolarised hair cells into the endolymph is 
an active ATP dependent process (Battey, Jr. 2000).
Figure 7: Potassium recycling in the cochlea (Adapted from www.ncbi.nlm.nih.gov)
A number of ion channels have been identified in the inner ear. Mutations in the 
potassium channel gene KCNQ4 result in a dominant form of progressive hearing loss 
(Kubisch et al 1999). This K+ channel is important for transporting ions out of hair cells. 
It is postulated that after the potassium ions leave the hair cells, they pass through a 
network of gap junctions between supporting cells and fibrocytes in the cochlea on to the 
marginal cells of the stria vascularis, which secretes potassium rich endolymph. A 
sodium-potassium-chloride co-transporter protein encoded by SLC2A2 helps to pump K+ 
ions into the marginal cells of stria vascularis, which secretes endolymph. Those mice 
with mutation in this gene have profound deafness as no endolymph is produced (Dixon 
et al. 1999). Layers of stria vascularis contain a number of specialised channels and
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pumps responsible for K+transport across it. The channels at the secreting surface of the 
marginal cells are made of proteins, encoded by the genes KCNQl (previously known as 
KvLQTl) and KCNE1 (previously known as ISK). Humans with mutations in the genes 
KCNQl (Neyroud et al. 1997) or KCNE1 (Tyson et al. 1997) suffer from Jervell and 
Lange-Neilsen syndrome. The mice with non functional KCNE1 gene have profound 
deafness and vestibular hypofunction as no endolymph is produced (Vetter et al. 1996). 
Inactivation of KCNQl gene in mice also results in profound deafness and vestibular 
abnormality (Lee et al. 2000).
1.3.3 Gap Junctions
Gap junctions (Figure 8) are sites of direct communication between adjacent cells. These 
are found both in invertebrates i.e. nematodes, echinoderms, ascidians, molluscs, 
arthropods and vertebrates i.e. frogs, chickens, rodents and humans (Wei et al. 2004). In 
invertebrates the gap junctions are encoded by the gene family known as innexins 
(Phelan & Starich 2001) and in the vertebrates, by the gene family connexins (Willecke 
et al. 2002). The gap junctions are present between supporting cells, but there are no gap 
junctions between hair cells. They are involved in several cellular functions including cell 
growth, differentiation, reaction to signals, synchronisation of activity in excitable tissues 
and homeostasis (Richard 2003).
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1.3.3.1 Structure of gap junctions
Gap junctions are formed of proteins called Connexins. All connexins have a common 
architecture. Six connexins form a hemi channel called a connexon (Figure 7) and the 
connexons of two adjacent cells join together to form the communication pathway 
between the cells called the gap junction (Kumar & Gilula 1996,Yeager 1998),. Each gap 
junction contains several thousand connexons (Forge & Wright 2002).
The connexon channels allow the passage of ions, metabolites up to 1.2kDa in size and 
second messengers (Kumar & Gilula 1996). The gap junctions provide a means to 
remove the K" ions from the intercellular spaces to maintain K+ homeostasis. The 
opening of gap junctions depends on calcium concentration, pH, transjunctional 
membrane potential and protein phosphorylation (Harris 2001).
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Figure 8: Structure of gap junctions (Adapted from www.Irz-muenchen.de)
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1.4 Connexins
Twenty one connexin genes have been identified in the human genome 
(http://www.ncbi.nlm.nih.gov/) and twenty in the mouse genome. Most of the connexin 
genes have a common structure (Figure 9). They consist of a first exon containing the 5f 
untranslated region (UTR), followed by an intron and a second exon containing the 
remaining S^UTR, the coding sequence and the 3/-UTR (Willecke et a l 2002).
GJB6 exon 1 GJB6 exon2 GJB2 exon 1 GJB2 exon2
Figure 9: Structure of Connexin genes
The connexins are named using two different nomenclature systems i.e. by molecular 
mass or based on sequence. For example the 43kDa connexin protein is referred to as 
either connexin 43 or di Connexin and Connexin 32 is also called pi connexin. The 
connexin proteins have been subdivided into three subgroups Connexin a, p or y. 
Sometimes a hybrid nomenclature can be used such that Connexin 43 or ai Connexin is 
called Connexin43di (Wei et a l 2004)
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Six connexins oligomerise to form a connexon, which represents half an intercellular 
channel. The properties of a gap junction depend on its constituent connexons. The gap 
junctions in a cell can range from few to over 105, resulting in a uniform phenotype to the 
cells (Simon & Goodenough 1998).
Cells and tissues can express more than one connexin isotype. A connexon composed of 
six identical subunits is called homomeric and if composed of more than one connexin 
isotype is called heteromeric (Figure 10).
Two identical connexons can form a homotypic channel (Figure 9). If the channel is 
formed by two connexons having different connexin isotypes, it is called a heterotypic 
channel.
Figure 10: Composition of Connexons (Adapted from www.kent.ac.uk)
1.4.1 Connexins in human disease
Connexins are proteins that are present ubiquitously. They have been implicated in 
pathogenesis of diseases in the epithelial system, nervous system, eye and ear(Chang et
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al. 2003). The diversity of diseases caused highlights the importance of connexins in 
different tissues and their functions. Different mutations in the same connexins can cause 
different tissue-specific diseases (GJB3 mutations cause both erythrodermia variabilis 
and autosomal dominant hearing loss). Also similar mutations in two different connexins 
can cause a single disease (Both GJA3 and GJA8 mutations cause cataract). Mutations in 
the genes of the GJB family causes epithelial disorders such as erytheroderma variabilis 
(GJB3, GJB4), palmoplantar keratoderma (GJB2), hidrotic ectodermal dysplasia (GJB6) 
and Vohwinkle syndrome (GJB2); the neurological disorder Charcot Marie Tooth 
disease(GJZ?/) and eye disorders such as cataract (GJA3,GJA8) (Chang et al. 2003).
Connexins expressed in the inner ear are Connexin 26, 30, 31 and 32 and mutations in 
these genes result in syndromic and non-syndromic deafness (Kelsell et al. 2001). 
Connexin gap junctions affect the ionic homeostasis of the cochlear epithelial cells and 
potassium recirculation from the hair cells to the endolymph (Kelsell et al. 1997,Saez et 
al. 2003,Chang et al. 2003). Impairment of normal ion channel function results in hair 
cell death and leads to sensorineural hearing loss (Rabionet et al. 2000,Saez et al. 2003).
1.4.2 Connexin 26
The Gap Junction Beta 2 gene, GJB2 gene encodes for the protein Connexin 26 (Kelsell 
et al. 1997). Mutations in the GJB2 gene are a common cause of deafness in many 
populations (Morell et al. 1998,Fstivill et al. 1998,Cohn et al. 1999). In 1994 Guilford et 
al. identified a non-syndromic recessive deafness locus, DFNB1, at chromosome 13q 12 
(Guilford et al. 1994). In 1997, mutations at this locus were identified to be mutations in 
the GJB2 gene (Kelsell et al. 1997), resulting in deafness. Connexin 26 deafness is now
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recognised as the most common genetic cause of congenital deafness in many countries 
accounting for up to 50% of recessive deafness (Green et al. 2003).
The protein Connexin 26 is highly expressed in epithelial supporting cells of the 
mammalian cochlea. In the rat cochlea Connexin 26 is expressed mainly in two groups of 
cells, non-sensory epithelial cells and connective tissue cells. The first group i.e. 
epithelial cells, include interdental cells of spiral limbus, inner and outer sulcus cells, 
sensory supporting cells and cells within the root process of the spiral ligament. The 
second group i.e. the connective tissue cells include fibrocytes within the spiral ligament 
and spiral limbus, basal and intermediate cells of stria vascularis and mesenchymal cells 
which line the scala vestibule (Kikuchi et al. 1995). Expression of Connexin 26 in the 
vestibular labyrinth is similar. Mutations in GJB2 cause deafness by altering Connexin 26 
function within the inner ear (Green et al. 2003).
1.4.2.1 Mutations in GJB2 (Genotype)
Approximately 110 non-syndromic deafness mutations have been identified in the GJB2 
gene. Of these 89 are recessive, 8 are dominant and 11 are of unknown significance.
Some mutations are highly prevalent in particular populations (Roux et al. 2004). In 
some countries where mutational spectrum is limited, specific testing for certain 
mutations will identify most cases. The common mutations identified in GJB2 have been 
the frameshift deletions 35delG, 167delT and 235delC and the large 342Kb deletion 
(Green et al. 2003).
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There is marked ethnic variation in mutations found. In Caucasians the 35delG mutation, 
accounts for the majority of GJB2 mediated hearing loss (Denoyelle et al. 1997,Sobe et 
al. 2000,Rothrock et al. 2003). The common mutations seen in other populations are- 
167delT in the Ashkenazi Jewish population (Lerer et al. 2000,Sobe et al. 2000),
235delC in the East Asian population (Kudo et al. 2001,Wang et al. 2002), R143W in the 
African population (Brobby et al. 1998,Hamelmann et al. 2001) and W24X in the Indian 
subcontinent (Rickard et al. 2001).
The most common mutation in the GJB2 gene is 35delG i.e. deletion of a single guanine 
from a series of six guanines. This results in a frameshift with premature termination of 
the protein. This mutation on its own accounts for nearly two thirds of the identified 
mutations in Caucasians. 35delG has been shown to be the most common mutation in 
patients with autosomal recessive sensorineural deafness from Australia, France, Israel, 
Italy. Tebanon, Morocco, New Zealand, Spain, Tunisia, UK and USA with relative 
frequencies ranging from 28% to 63% (Denoyelle et al. 1997,Scott et al. 1998,Estivill et 
al. 1998,Tench et al. 1998). The reason for this mutation being so common was earlier 
suggested to be due to the fact that 35delG is located in a hypermutable region 
(Denoyelle et al. 1997). As the prevalence of 35delG varies between different ethnic 
groups, an alternative to the mutation hot spot theory was proposed which was that the 
high frequency of this variant results from a common founder living 10000 years ago 
(Van Laer et al. 2001). 35delG is now accepted as a founder mutation.
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The 167delT is the second most common GJB2 mutation described and is highly 
prevalent in the Ashkenazi Jewish population (Sobe et al. 2000). This mutation also leads 
to a frameshift and premature truncation. Sobe et al in their study of 75 Jewish hearing 
impaired subjects from Israel, have reported GJB2 mutations in 29 patients (38.7%)
(Sobe et al. 2000). Of these, 20 had the 35delG mutation (11 homozygous, 5 compound 
heterozygote with 167delT, 4-second mutation not found) and 13 had the 167delT 
mutation (8 homozygotes and 5 compound heterozygotes with 35delG) and 1 patient had 
a novel GJB2 deletion/insertion mutation (5 ldell2insA).
W24X (Tryptophan mutated to stop codon) is an inactivating mutation which was 
originally reported by Kelsell in two unrelated Pakistani families with profound deafness 
(Kelsell et al. 1997). In addition the mutation has been found to be common in Indian 
families (Scott et al. 1998,Rickard et al. 2001,Ghosh et al. 2004) and in one Thai patient 
(Kudo et al. 2001) which suggests that this mutation originates from the Asian 
population.
In a study on 11 families from a village in Ghana with high prevalence of hearing loss, 
Brobby identified R143W mutation as the cause of hearing loss in all of these families 
(Brobby et al. 1998). Another study of 365 unrelated individuals from all over Ghana 
found GJB2 mutations in 63 patients( 17%) (Hamelmann et al. 2001). Of these, 51 were 
homozygous for R143W mutation, 8 were heterozygous for R143W and 4 had other 
GJB2 mutations. In this population from Ghana R143W contributed to 90% of all GJB2 
mutations seen.
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Most GJB2 mutations cause autosomal recessive non-syndromic hearing loss (DFNB1) 
although a few mutations have been identified in dominantly inherited hearing loss 
(DFNA3) (Morle et al. 2000,Loffler et al. 2001 ,Hamelmann et al. 2001). Dominant 
Connexin 26 deafness (DFNA3) has been identified in families with mutations, R184Q, 
W44C and C202F (Denoyelle et al. 1998,Morle et al. 2000,Hamelmann et al. 2001) and 
also R75W (Richard et al. 1998).
GJB2 mutations can also cause hearing loss in combination with GJB6 (del Castillo et al.
2003). The GJB6 gene encodes the protein Connexin 30, which can oligomerise with 
Connexin 26 in the same gap junction (Ahmad et al. 2003). See section 1.4.3 for further 
explanation of this mutation.
A more complete list of mutations is available at the connexin deafness homepage
http'.A'www .criz.es/deafness.
1.4.2.2 Connexin 26 deafness (Phenotype)
The severity of deafness in patients who have mutations in GJB2 varies. In early studies 
Connexin 26 positive patients, profound deafness was found in 50%, severe in 30.2%, 
moderate in 18.1% and mild deafness in 1.7% patients (Steel 1998,Cohn et al. 
1999,Mueller et al. 1999). However the severity of hearing loss can vary even amongst 
patients with the same mutations.
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Almost all patients with deafness due to Connexin 26 have a flat or down sloping 
audiogram (Green et al. 2003). In few Connexin 26 patients, U shaped audiograms have 
been reported by Mueller (Mueller et al. 1999). Mueller reported 4 of 31 patients with U 
shaped audiogram (mutations associated with U shaped audiogram not clearly stated). 
Selective low frequency hearing loss has not been identified in Connexin 26 deafness.
Most of the patients with Connexin 26 deafness have symmetrical hearing loss. Inter- 
auricular differences in the hearing thresholds have been reported in less than one quarter 
of the patients (Denoyelle et al. 1999,Cohn et al. 1999) with the difference usually less 
than 20dB.
Most individuals with Connexin 26 deafness have congenital hearing loss. In most of the 
patients, progression appears to be slow or nonexistent. However some authors have 
reported progression (Denoyelle et al. 1999,Cohn et al. 1999). Two of 16 children 
studied by Denoyelle et al over 10 years have shown progression (Denoyelle et al. 1999). 
Cohn et al have reported progression of hearing loss in 7 out of 30 patients over at least 6 
years (Cohn et al. 1999). On the other hand none of the 12 patients in the study by 
Wilcox et al showed progression (Wilcox et al. 2000) and Mueller et al did not report 
any progression in the serial audiograms of 24 patients with GJB2 mutations (Mueller et 
al. 1999). Patients with Connexin 26 hearing loss have loss of brainstem auditory evoked 
responses and otoacoustic emissions.
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Connexin 26 deafness is usually audiologically quite stable. However in view of reports 
of progression, it is probably wise to follow up patients annually unless their hearing loss 
is already profound.
Patients with Connexin 26 positive do not have any bony abnormalities of the cochlea. 
Also these individuals have normal vestibular function and normal developmental motor 
milestones (Denoyelle et al. 1999,Green et al. 2003). In a study of 104 families (140 
children) with sensorineural deafhess, Connexin 26 deafhess was present in 49% of 
families with prelingual deafhess (Denoyelle et al. 1999). They concluded that Connexin 
26 deafhess varied from mild to profound, had a flat or sloping audiometric pattern and 
radiologically the inner ear was normal. Green et al collected data from patients at 
University of Iowa & Arizona Connexin deafhess consortium and concluded that 
Connexin related deafhess was usually bilaterally symmetrical, congenital with no 
medical co-morbidities or vestibular abnormalities (Green et al. 2003).
1.4.23 Genotype Phenotype correlation
In non-syndromic deafhess there seems to be some correlation between specific GJB2 
mutations and the phenotype on audiometric examination, although there is significant 
variability. Those mutations in the GJB2 gene which completely inactivate the Connexin 
26 synthesis (stop mutations or frameshifts) generally cause severe to profound hearing 
loss as compared to the non-inactivating mutations (missense mutations) or splice site 
mutations where some Connexin 26 protein is likely to be synthesised (Cryns et al. 
2004,Snoeckx et al. 2005).
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In a multicentre study of 277 unrelated patients with GJB2 mutations from Belgium,
Italy, Spain and United States it was found that 35delG homozygotes have significantly 
more severe hearing impairment compared with 35delG/non-35delG compound 
heterozygotes (Cryns et al. 2004). The authors also reported that two non-35delG 
mutations have even less hearing impairment i.e. non 35delG/non35delG. As a follow up 
study, GJB2 genotype and phenotype in 1,531 patients with non-syndromic autosomal 
recessive hearing loss, from 16 countries were analysed (Snoeckx et al. 2005). It was 
found that hearing loss in patients with homozygous protein truncating mutations the 
hearing loss was significantly more severe than in patients with homozygous non­
truncating mutations. It was also reported that hearing loss with 48 different genotypes 
was less severe than those who were homozygotes for 35delG. Other mutations such as 
M34T, V37I and L90P resulted in mild to moderate deafness. On the other hand 
35delG/R143W and 35delG/delGJB6 had significantly more severe deafhess than 
35delG/35delG.
1.4.2.4 Cochlear implantation in Connexin 26
In patients with Connexin 26 deafhess the neural structures are preserved, and these 
individuals do not have cognitive dysfunction. For these reasons it is expected that such 
patients would do well with cochlear implantation. It has been shown in some studies that 
cochlear implantation in children with Connexin 26 deafness has good results 
(Fukushima et al. 2002,Green et al. 2002,Matsushiro et al. 2002,Bauer et al. 2003) while 
others have reported no difference in the results (Cullen et al. 2004)
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In another study 55 children who had been implanted before the age of 5 years were 
analysed (Bauer et al. 2003). Of these 22 children had GJB2 related deafness and 33 were 
GJB2 negative. It was seen that all children had benefit from cochlear implantation in the 
areas of speech production, speech perception and language. There was a significant 
positive difference in the cognitive and reading performance in children with identified 
GJB2 mutations compared with those who were negative for GJB2 mutations. The 
explanation for this is thought to be that GJB2 mutations cause an isolated insult to the 
cochlea without damage to the auditory nerve or the central auditory system. Though the 
hearing loss in other children may be isolated and non-syndromic, there may have been 
subtle additional disabilities due to central effects.
In another study cochlear implantation in 8 GJB2 positive patients of the 20 patients in 
the study group, had better results in terms of hearing as compared to other congenitally 
deaf cochlear implant patients and non-cochlear implant recipients (Green et al. 2002),.
In a different study (Matsushiro et al. 2002), four patients with prelingual deafness with 
the 235delC mutation clearly benefited from cochlear implantation and performed better 
than implanted patients with no GJB2 mutations. In Fukushima’s study, three patients 
with GJB2 related deafness had better speech as compared to four other children with non 
GJB2 related deafness (Fukushima et al. 2002). Sinnathuray et al compared 11 patients 
with GJB2 mutations with 20 patients with GJB2 unrelated deafness (Sinnathuray et al.
2004). They found that children with GJB2 related deafness had equal or better speech 
discrimination on comparison with the other group with deafness of unknown cause.
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Cullen compared 20 patients with GJB2 mutations with 27 without mutations in GJB2 
(Cullen et al. 2004). In this study they found that the presence or absence of GJB2 
mutations did not have any significant impact on the speech performance at 12, 24 and 36 
months after cochlear implantation.
1.4.3 Connexin 30
Connexin 30 is encoded by the gene GJB6. GJB6 is a gene adjacent to GJB2 on 
chromosome 13. Both of these genes are expressed in the cochlea and form multiunit gap 
junction channels. Mutations in either or both loci can cause deafness (del Castillo et al. 
2002). Deafness manifests only when the patient has two mutations on opposite 
chromosomes. The most common mutation in GJB6 is a 342kb deletion which causes 
non-syndromic hearing loss when homozygous or when present on the opposite allele of 
a GJB2 mutation (del Castillo et al. 2002). This deletion truncates the GJB6 gene but 
does not affect the GJB2 structural gene. The deafness caused by GJB6 deletion is 
explained by the hypothesis that there must be a regulatory element located upstream of 
GJB2 and the deletion of this element would suppress the level of expression of GJB2 
enough to produce a phenotype of hearing impairment (Castillo et al. 2002). The hearing 
loss can range from mild to profound (Stevenson et al. 2003).
The 342kb deletion in GJB6 gene is the second most common mutation causing hearing 
loss in Spanish population (Castillo et al. 2002).
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1.5 Deafness in Bangladeshi children in East London
Bangladesh is a country in South Asia bounded by India from the north, east and west 
and Bay of Bengal and Burma from the south. Dhaka is the capital and largest city of 
Bangladesh. Bangladesh is divided into 6 divisions, all named after their respective 
capitals. These are Sylhet, Chittagong, Dhaka, Khulna, Rajshahi and Barisal.
The population of Bangladesh is nearly 150 million with about 40% of the population in 
0-14 years age group, 57% in 15-64 years and 3% in 65 years and over. Apart from very 
small countries such as Singapore and Bahrain, Bangladesh is the most densely populated 
country in the world.
Despite sustained domestic and international efforts to improve economic and 
demographic prospects, Bangladesh remains a poor and overpopulated nation. Major 
impediments to growth include frequent cyclones and floods, inefficient state owned 
enterprises, a rapidly growing labour force that cannot be absorbed by agriculture, 
inefficient use of energy, insufficient power supplies and slow implementation of 
economic reforms (Sylhet Corp. 2005).
The population of Bangladesh is ethnically homogeneous, with Bengalis comprising 98% 
of the population. The vast majority of population (98%) speaks Bangla (sometimes 
called Bengali), the official language, and the remaining two percent are Urdu speaking. 
Most Bangladeshis (83%) are Muslims, but Hindus constitute a sizeable (16%) minority.
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The dialects of Sylhet, Chittagong and Noakhali are strongly marked by Arab-Persian 
influences.
1.5.1 Sylhet
Sylhet is situated in the north eastern region of Bangladesh (Figure 11). It has a 
population of 0.7 million people and is called the tea granary of Bangladesh. It has 
over 150 tea gardens and also possesses the three largest tea gardens in the world with 
respect to dimension and production.
Figure 11: Map of Bangladesh showing Sylhet (Adapted from fr.wikipedia.org)
Sylhet belongs to a group of medium urban centres that have grown rapidly in last few 
years. The population density is estimated to be 2800 people per square mile. The health 
of the citizens of Sylhet is affected by lack of urban housing, air quality and lack of 
education and basic infrastructure.
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1.5.2 The Bangladeshi population in East London
East London contains the highest number of Bangladeshis outside Bangladesh and the 
Bangladeshi population living in London is mainly concentrated in the boroughs of 
Tower Hamlets, Newham and Hackney. In Tower Hamlets, according to the 2001 census, 
over one third (33%) of the population of the borough is Bangladeshi, of whom half are 
under 20 years old. Almost all the Bangladeshi population living in this borough 
originates from the province of Sylhet and Tower Hamlets has the largest Sylhetti 
population in the world outside Bangladesh.
The population of Tower Hamlets is very interesting from the social and economic point 
of view. It is set to increase faster than the rest of London between now and 2011. Tower 
Hamlets has a much younger population than the rest of London and UK. It has the 
largest percentage of 20 to 34 year olds of any local authority in UK. 57% of the 
population are 15-44 years old compared with 41.5% for this age group for the country as 
a whole. The situation is reversed for 45-79 years old (Research & Scrutiny 2004).
Most of this difference between Tower Hamlets and the rest of London and the UK is due 
to the Bangladeshi population. The number of Bangladeshis under the age of 18 is almost 
double the proportion for all Londoners. This is a result of high fertility rates in this 
community. Most Bangladeshi children in London were bom in UK while most adults 
were bom in Bangladesh (GLA Data mangement and analysis group 2004).
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Age profiles are very different for the two major ethnic communities in Tower Hamlets - 
White British and Bangladeshis. For the White British community, 40% are below the 
age of 30 and 12.5% are below 15 years of age. In the Bangladeshi community 70% are 
below 30 and 40% are below the age of 15 years.
According to the Indices of Deprivation, Tower Hamlets ranks as the second most 
deprived local authority in England (Research & Scrutiny 2004). The indices used 
include employment, health and disability, education skills and training, housing, living 
environment and crime (Office of National Statistics 2001).Tower Hamlets has a low life 
expectancy both for males and females as compared to national levels. The literacy rate 
amongst Bangladeshi women is low and very few of the women can communicate in 
English (Research & Scrutiny 2004).
Britain’s Bangladeshi community lives with greater overcrowding than any other ethnic 
group (Kempson 1999). Nineteen percent of Bangladeshis live at a housing density of 
more than 1.5 persons per room, compared with 0.5% of the population as a whole 
(Kempson 1999).
Thus the demographics of population in Tower Hamlets make the borough exceptional in 
contrast to regional and national trends. This has an impact on delivery of local services 
in the future.
55
1.6 This study
In 1993, Vanniasegaram et al, in a 5 year review reported the prevalence of deafness in 
East London to be three times the national average (Vanniasegaram et al. 1993). They 
also reported that the prevalence among Bangladeshi children living in Tower Hamlets in 
East London was about 6 times the national average. A comparison of the rates of 
deafness among Caucasian and Bangladeshi children in Tower Hamlets, showed the 
prevalence to be greater among the Bangladeshi children. This was attributed to high 
rates of consanguinity, although evidence for this was not presented.
1.6.1 Objectives of the study
In view of the expansion of the Bangladeshi population in East London within the last 
decade, the increase in knowledge of genetic causes of deafness with the possibility of 
molecular diagnosis and the advent of Newborn Hearing Screening, it was decided to 
review the prevalence and causes of deafness in this population in some detail. The 
objectives of this study were:
1. To determine the prevalence of deafness among the Bangladeshi population in 
2005 and to compare this with national prevalence figures of Fortnum et al 
(Fortnum et al. 2001).
2. To review the causes of deafness generally.
3. To determine the genetic causes of deafness in this population:
i. To test for GJB2 and determine its contribution to deafness
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ii. To identify families suitable for linkage mapping in order to 
identify other genes segregating in this population.
4. To review the attitudes of this population to hearing loss and to genetics.
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2 Patients & Methods
The primary aims of this project were to determine the prevalence of deafness in the 
Bangladeshi population of East London and to determine causes of the deafness.
2.1.1 Ethical Committee approval
This project was registered with the Research and Development office at Great Ormond 
Street Hospital and the Institute of Child Health (R&D Registration number: 03CM16) by 
Mr Yogesh Bajaj. Ethical committee approval for this project was obtained from the 
Research Ethics Committee at Great Ormond Street Hospital & Institute of Child Health 
as well as City & Hackney NHS trusts in December 2003 for Mr Yogesh Bajaj, Dr 
Bitner-Glindzicz and Dr Sirimanna to conduct the project. This study entailed analysis of 
the patient records for all the patients, and recruitment of selected patients for further data 
collection and blood sampling for genetic analysis.
2.2 Patients
2.2.1 Patient ascertainment
In order to determine prevalence, as complete an ascertainment as possible was 
attempted. Details of children of Bangladeshi ethnic origin with hearing loss were 
obtained from various sources (Audiology database, Teachers of Deaf database, and 
individual Consultant’s records). The records maintained by the audiology department at 
the Donald Winnicot Centre, of the children who have been issued with hearing aids in 
the past, were cross checked with the records of the Teachers of Deaf involved with these 
children.
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The Donald Winnicot Centre (DWC) is a multidisciplinary community based clinic in 
Hackney which provides primary and secondary level health services including 
audiological services to the population in Tower Hamlets and Hackney districts. It is 
affiliated with Great Ormond Street Hospital for Children and Institute of Child Health, 
which provides tertiary level paediatric audiology services. All these patients were under 
the care of Consultant audiological physicians. The patients were seen at a research clinic 
in the audiology department at the Donald Winnicot Centre.
2.2.2 The study group
The Bangladeshi population living in East London is concentrated mainly in Tower 
Hamlets and Hackney health districts (Office of National Statistics 2001). The patients 
included in this study were all the Bangladeshi children on the records of Donald 
Winnicot Centre (DWC) with bilateral sensorineural hearing loss of more than 40 dB in 
the better hearing ear.
The Pure Tone threshold was calculated by taking the average of four frequencies -500, 
1000, 2000 and 4000 Hz. The most recent audiogram was used to categorise the severity 
of hearing loss and the better hearing ear was used to classify the severity of hearing loss 
(as described in definitions section) (Stephens 2001). The shape of the audiograms were 
also recorded (Stephens 2001)
The data was collected from the patient notes (180) of all the children ascertained from 
different sources. Those children with conductive deafness or not actually of Bangladeshi 
origin were excluded from the study at this stage (34). Also patients with mild
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sensorineural hearing loss i.e. less than 40 dB (8), and those with unilateral sensorineural 
hearing loss (4) were excluded from this study. In other words all children of Bangladeshi 
ethnic origin with bilateral sensorineural hearing loss more than 40dB in the better 
hearing ear were included in this study (Figure 12).
Case Notes Screened 
(180)
Patients eligible for Patients excluded from
study (134) study (46)
Cause of deafness 
known (52)
Cause of deafness 
unknown (82)
1
Invited for Research 
project (82)
Declined to 
participate (11)
Could not be 
contacted (4)
Seen in research 
clinic (67)
V Included in this study . .............j r---------------- w (119)
Figure 12: Patients selection for the study
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2.3 Methods
2.3.1 Information about research
Information leaflets about the research project were prepared for parents and children by 
Mr Yogesh Bajaj in English, and translated into Bengali by professional translators. 
Sylhetti, the dialect spoken by this Bangladeshi community does not have a written script 
and so further provision was made for parents who could not read English or Bengali and 
could only speak Sylhetti. Audio tapes in Sylhetti were recorded by a Sylhetti speaking 
link worker, working with deaf children and their families (Ms Shabnam Sattar). The 
tapes were essentially translation of the information leaflet in the Sylhetti dialect. The 
information leaflets in English and Bengali translation are attached as appendix 10.3. The 
audio CD with the Sylhetti translation of the information leaflet is available on request.
2.3.2 Investigations
Most patients were regularly under the follow up of Consultant audiological physicians at 
Donald Winnicot Centre and Great Ormond Street Hospital. Many of the patients had 
already been investigated for their deafness. The tests included: full blood count, urea & 
electrolytes, thyroid function tests, ESR, urine analysis, ECG, ultrasound of kidneys, and 
CT scan of temporal bones. If the history had suggested teratogenic cause, the patients 
had been tested for common infectious diseases (toxoplasma, rubella, cytomegalovirus, 
herpes simplex, syphilis). A pre-printed list of investigations was used to request 
investigations for these patients at Great Ormond Street hospital. For most of the patients 
seen until 2-3 years ago, no genetic testing had been requested.
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The serial hearing tests of these patients were recorded in the notes or were in the 
audiology records at Donald Winnicot Centre. The hearing had been assessed by pure 
tone audiometry in the older children and by sound field tests and Brainstem evoked 
response audiometry in the younger children.
2.3.3 Data Collection
The data collected included detailed history of hearing loss and the medical history, 
examination findings, audiological information on patients and parents and results of 
investigations. After the data collection at this stage patients were discussed at meetings 
with Dr Bitner-Glindzicz and Dr Sirimanna regarding inclusion into or exclusion from 
the study. Selected data were entered onto a Microsoft Access database designed by Mr 
Yogesh Bajaj for this purpose. At this stage, the patients were classified into two main 
groups-‘Cause of deafness known’ and ‘Cause of deafness unknown’.
2.3.4 Population Data
General demographic information about the Bangladeshi population in the UK was 
requested from the Research & Development office in Tower Hamlets and the Census 
office (Office of National Statistics 2001). Relevant information about the Bangladeshi 
population living in Tower Hamlets and Hackney had to be extracted from the available 
Census data. The relevant information is attached as appendix 10.6
2.3.5 Research Clinic
For those patients in whom the cause of deafness was not clear from the records or 
unknown (or non-syndromic deafness), families were invited to be seen in the research 
clinic by Mr Yogesh Bajaj specifically for this study. The invitation involved explaining
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the research to the parents over the telephone in English or in Sylhetti, if they did not 
understand English. This was followed up by written information in English and Bengali 
sent to these patients by post. Those who agreed to participate were given appointments 
to be seen in the research clinic at Donald Winnicot Centre.
All the patients were seen in the presence of Sylhetti speaking liaison worker (Ms 
Parveen Quader), who knew the families well. The role of the Sylhetti liaison worker has 
been vital for this project as the patients felt very comfortable in her presence. Written 
informed consent was obtained from the patient or the parents, in English or Bengali. For 
these patients and their families seen in the research clinic, detailed history and 
examination was carried out and blood samples were collected from the patient and the 
parents for genetic analysis. Blood samples were also taken from siblings if the parents 
were consanguineous. This was for possible future use for mapping studies.
2.3.6 Genetic analysis
The DNA was extracted at the North East Thames Regional Clinical Molecular Genetics 
laboratory under quality assured conditions and screened for mutations in GJB2 by Ms 
Lucy Jenkins in the North East Thames Regional Clinical Molecular Genetics laboratory. 
All the samples were screened for mutations in the coding region (exon 2) and also for a 
splice site mutation (IVS 1 +1) and the 342kb deletion.
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23.6.1 GJB2 Analysis
Performed by Lucy Jenkins, Clinical Scientist at the Molecular Genetics laboratory.
2.3.6.1.1 PCR amplification
The GJB2 gene was amplified by PCR in several fragments; the non-coding exon 1 
including its splice site primers was amplified and the coding exon 2, which was 
amplified in three fragments 2A, 2B and 2C. After PCR, these reactions were performed 
spiked with a known wild type DNA and subject to DHPLC analysis.
Prior to loading onto the WAVE™ machine for DHPLC analysis, heteroduplex formation 
was carried out on the PCR products by denaturing at 95°C for 5 minutes followed by 1 
minute cycles starting at 95°C and decreasing by 1°C per cycle for 46 cycles. 
Heteroduplexed PCR products underwent DHPLC analysis at the following temperatures; 
exon 2 A at 61.8°C, exon 2 B at 60.4 °C and 61.8 °C, and exon 2 C at 57.5 °C and 60.0 °C.
Table 4: Primers used for connexin 26 analysis.
Primer Primer Sequence Size Reference
Exon 1 1 F 5’TCCGTAACTTTCCCAGTCTCCGAGG
GAAGAG3’
1 R 5’CCCAAGGACGTGTGTTGGTCCAGC
CC3’
Exon 2 A CX26 AF 5’TCTTTTCCAGAGCAAACCGC3’
(bp)
360 (Kelsell et 
a l 1997)
287 (Kelsell et 
a l  1997)
CX26 AR 5’GACACGAAGATCAGCTGCAG3’ 
Exon 2 B CX26BF 5’CTGGTGCTACGATCACTAC3’ 
CX26BR 5’TTCCAGACACTGCAATCATG3’ 
Exon 2 C CX26CF 5TATGTCATGTACGACGGCT3*
CX26CR 5 ’TCT AAC A ACTGGGC AATGC3 ’
410 In house
239 In house
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Table 5: PCR Conditions to amplify GJB2 in three fragments for DHPLC analysis
Exon 2 Fragment
A B C
PCR Product size (bp) 287 410 239
Reaction volume (dl) 30 30 30
Primer concentration 5 5 5
(pmol / reaction) 
Annealing temp. (°C) 63 62 62
Polymerase Megamix W* Platinum Taq** Megamix W*
Magnesium Chloride - 2mM -
dNTP - 200pM -
* Megamix W (Microzone) contains magnesium (final concentration 2.5mM) and 
dNTPs (final concentration 200pM) but excludes BSA to allow DHPLC analysis.
** Invitrogen
2.3.6.1.2 Sequence analysis
Variants detected by DHPLC analysis were characterised by direct sequence analysis. 
Fragment Exon 2 A was sequenced using the same primers used for PCR amplification, 
while fragments B and C were amplified and sequenced together as a 516 base pair 
product using CX26 BF and CX26CR. Bi-directional sequencing was carried out using 
Big Dye Terminator reactions followed by sodium acetate and ethanol precipitation then 
70% ethanol wash. Sequencing products were analysed using an ABI 3100 or 3730 
genetic analyser.
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Exon 1 splice site mutation detection
Exon 1 and its exon-intron boundaries were amplified with primers. The splice mutation 
I VS 1 + 1 removes a Hph\ site and is therefore detected using restriction digest analysis of 
PCR products resolved on a 2% agarose gel.
2.3.7 Attitudes to Genetic testing
In the research clinic, families were also asked some general questions to assess their 
attitudes towards genetic testing. The parents and patients who agreed to participate in the 
research were asked their reasons for participation and about their attitudes to genetic 
testing, counselling and pre-natal diagnosis.
2.3.8 Follow up
For all the patients who were seen in the research clinic, letters were written to their 
General Practitioner and their primary audiology consultant informing them of the 
participation in the research project. Also these patients were sent letters to thank them 
for participating in the research. At regular intervals letters have been written to all these 
patients and parents informing them about the progress of the research. As the results of 
GJB2 mutation screening become available, letters were written to the parents, their 
General Practitioners and the Consultants. Those patients who were found to be positive 
for mutations in GJB2 were invited to come to genetic clinic to be seen by Dr Bitner- 
Glindzicz.
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3 Prevalence of Deafness
3.1 R esults
3.1.1 Families
One hundred and thirty four patients (115 families) were eligible to be included in this 
study. These patients were divided into two groups. Of these 11 patients (11 families) 
declined to participate and 4 patients (4 families) could not be contacted. Thus for the 
purpose of elucidating the cause of deafness 119 patients (100 families) were included. 
Of these 67 patients (53 families) had children with undetermined cause and 52 patients 
(47 families) had children with cause of their deafness diagnosed. Those patients in 
whom the cause of deafness was not known were invited to come to the research clinic.
3.1.2 Demographics of the study group
The patients in this study ranged from 9 months to 27 years of age. The average age at 
the time of recruitment in this project was 11 years 6 months, although most of the 
patients (121/134) were less than 18 years of age at the time of recruitment. In this study 
group there were 71 (52.9%) males and 63 (47.1%) female patients. All the subjects had 
parents or grandparents bom in the province of Sylhet in Bangladesh. The duration of 
patients’ hearing loss was in the range of 1 month to 26 years.
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3.1.3 Prevalence of deafness in Bangladeshi children
The total population of Bangladeshis living in Tower Hamlets & Hackney districts in 
East London was 71,525 in 2001 (Office for national statistics 2001). Of these, there 
were 28,497 children less than 16 years as per 2001 census (Appendix 10.6).
In the course of this study, 134 deaf children with a permanent bilateral sensorineural 
hearing loss greater than 40dB in the better hearing ear, living in these two districts at the 
time of census in 2001, were ascertained from all sources and 110 of these children were 
aged up to 16 years of age (less than 16) in 2001. Thus the prevalence of deafness in 
Bangladeshi children in 2001 was at least 3.86 per 1000 (95%CI: 3.24, 4.47). This may 
be an underestimate as we may have incompletely ascertained some individuals, although 
all efforts have been made to trace these children using different sources.
3.1.3.1 Effect o f Consanguinity
Vanniasegaram attributed the high prevalence of deafness in this community to 
consanguinity (Vanniasegaram et al. 1993). We wished to try and determine whether this 
was truly the case. There are no figures for consanguinity rates in Tower Hamlets as this 
data is neither collected during the census or locally by the Tower Hamlets authorities. 
Estimates of probable consanguinity rate therefore had to be made from published data 
(Durkin et al. 2000). Durkin et al estimated the consanguinity in the urban Bangladeshi 
population in Bangladesh to be 10.6% and thus 10.6% was used to estimate the probable 
consanguinity rate among the parents of hearing children in Tower Hamlets. On 
removing 10.6% from 28,497 we are left with overall population of 25,809 children less 
than 16 years of age whose parents would not be consanguineous.
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Among the children with deafness, 110 were less than 16 years of age in 2001, 40 
children had consanguineous parents, leaving 70 deaf children who did not have 
consanguineous parents. On calculating the prevalence of deafness in these Bangladeshi 
children belonging to non-consanguineous families, the prevalence falls to 2.72 per 1000 
(95%CI: 2.10, 3.34). The prevalence in this Bangladeshi population is still higher than 
the national figure of 1 to 2 per 1000 (95%CI: 2.02, 2.08) (Fortnum et a l 2001), so the 
excess can not be accounted for by consanguinity alone.
Table 4: Prevalence in British Bangladeshi children less than 16 yrs in 2001 
Population Prevalence 95% Confidence intervals
Whole population 3.86 per 1000 3.24 to 4.47 per 1000
Non-consanguineous 2.72 per 1000 2.10 to 3.34 per 1000
population
Given the possibility that the estimate of background consanguinity in Tower Hamlets 
was taken to be 10.6%, it was important to determine whether errors in this estimate were 
likely to affect our calculations of prevalence of deafness. Figure 13 (Courtsey M 
Cortina-Borja, Senior Lecturer in Statistics, Institute of Child Health) shows that there are 
no substantial changes in the prevalence of deafness in non-consanguineous marriages 
with respect to possible values of the proportion of consanguineous marriages (between 
5% and 20%) in the background Bangladeshi population; the prevalence estimates vary 
between 2.81% (95% confidence intervals 2.21 to 3.51) and 3.34% (95% confidence
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intervals 2.63 to 4.17). The background prevalence of deafness in UK and its confidence 
intervals are shown for comparison (as calculated by Fortnum et al.)
o p=10%
o
CO
m
c\i
adjusted UK prevalence= 2 05%
005 0 200.10 0.15
proportion of consanguineous marriages
Figure 13: Prevalence of deafness vs consanguinity (The graph shows how the 
prevalence of deafness in non-consanguineous families would change with 
consanguinity from 5% to 20%. The solid line in the graph [marked p=10%] along 
y axis indicates the prevalence with 10% overall consanguinity)
3.1.4Consanguinity in the study group
Information about consanguinity was available in 105 families, of which parents were
consanguineous in 35 (33.3%). Of these, 26 parents were first cousins, 7 second cousins 
and 2 were third cousins.
Table 5: Consanguineous families: Total-35
Relationship between parents Number of families Percentage
First cousins 26 74.2%
Second cousins 7 20.0%
Third cousins 2 5.7%
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3.2 Discussion
In the UK the prevalence of confirmed permanent childhood hearing impairment between 
0 and 3 years is 0.91/1000 children (95% confidence intervals 0.85 to 0.98) rising to 
1.65/1000 (1.62 to 1.68) for children aged between 9 and 16 years according to Fortnum 
et al (Fortnum et al. 2001,Fortnum 2003). Adjustments for under-ascertainment increased 
estimates to 1.07 (1.03 to 1.12) and 2.05 (2.02 to 2.08) respectively (Fortnum et al 
2001).
In this study the prevalence of deafness in children of Bangladeshi origin resident in East 
London up to 16 years of age was calculated to be at least 3.86 per 1000 which is 2.3 
times the national average of 1.65 / 1000. In Vanniasegaram’s study, performed nearly 15 
years ago, the prevalence of deafness in Tower Hamlets in East London was reported to 
be three times the national average (Vanniasegaram et al. 1993) and the higher 
prevalence among British Bangladeshi children was hypothesized to be secondary to high 
rates of consanguinity in this ethnic group although no data were presented. Higher 
prevalence of deafness in a number of different immigrant ethnic groups in the UK has 
been previously reported; Morton (Morton et al. 2002) reported a prevalence of deafness 
of 3.67/1000 children in a Pakistani population from South Derbyshire, and Naeem and 
Newton found a prevalence of 6.79 per thousand in Asian children aged 5-16 years 
compared to 2.1 per thousand for non-Asian children (using a hearing loss of 20dB or 
more, rather than 40dB used here for case ascertainment) (Naeem & Newton 1996). In 
these studies the excess of childhood deafness was also attributed to genetic causes 
secondary to the practice of consanguineous marriage.
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It has been anecdotally known that cousin marriages were common in the Bangladeshi 
community. Durkin et al found that consanguinity was nearly 10% in the general urban 
Bangladeshi population (Durkin et al. 2000). The reason for high consanguinity is usually 
cited as arranged marriages, whereby parents arrange marriages amongst their relatives 
whom they know. The other reason cited is that if they are married to relatives, the family 
wealth stays within the extended family.
Amongst this whole study group of Bangladeshi children with hearing loss, the 
consanguinity was found to be nearly 34% amongst parents i.e. more or less 1 in every 
three families. Most of these parents (75%) were first cousins.
In the British Bangladeshi population our analysis suggests that consanguinity contributes 
to the raised prevalence of deafness. However removal of those children bom of 
consanguineous marriages from the calculation does not reduce the prevalence to the 
national figure. It is likely therefore that environmental factors may also play a part in the 
high prevalence of deafness.
The environment of Tower Hamlets is unusual for many reasons; the borough of Tower 
Hamlets, where 33.4% of residents are of Bangladeshi origin (Office of National 
Statistics 2001), is ranked as the 2nd most deprived out of 384 in the country, has high 
unemployment rates and is overcrowded (10,462 people per square kilometer compared 
with 4679 for the region and 380 for England overall). The total fertility rate in Tower 
Hamlets is 1.84 compared to 1.64 for UK and Bangladeshis in general tend to have large
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families. For example in London generally, 57% of Bangladeshi households have two or 
more dependent children compared with the London average of 17% and only 8% of 
Bangladeshi households are single person households (Research & Scrutiny 2004). It is 
possible that an environmental agent known to cause deafness, which is more prevalent 
where there is overcrowding and which associated with poorer socio-economic 
conditions might also account for some of this increase in prevalence.
Cytomegalovirus is now recognized as the most frequent cause of congenital infections in 
humans and is the leading acquired cause of congenital sensorineural hearing loss 
(Vallely et al. 2002). It occurs in approximately 1% of all newborns and hearing loss, 
which can range from mild to profound, is the most common neurological impairment 
associated with congenital CMV infection. As only 10% of infants with congenital CMV 
are symptomatic at birth it can be extremely difficult to diagnose in the majority of cases. 
Of the asymptomatic infants, 5% can later manifest symptoms of the disease including 
hearing loss. Another 10-15% of those asymptomatically infected at birth can develop 
progressive hearing loss. This could represent the reactivation of the virus to an unknown 
stimulus (Lucas 2002). Thus, although speculative, it is possible that congenital CMV 
infection may account for some of the increase in prevalence of deafness in the 
Bangladeshi population of East London.
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4 Causes of deafness
4.1 Classification
The causes of deafness were classified into three main groups: genetic, acquired
(environmental) and unknown. The deafness was classified as genetic if it was syndromic 
or chromosomal or non-syndromic with a definitive inheritance pattern (dominant, 
recessive or X-linked). For those with genetic deafness, mode of inheritance was 
designated as autosomal recessive if more than one child in the family of normally 
hearing parents was deaf, or if parents stated that they were consanguineous and no other 
cause of deafness could be determined, or if the child was positive for GJB2 mutations on 
subsequent testing.
4.1.1 Causes for the whole study population
The causes of deafness are shown in Table 6.
Table 6: Causes of deafness before GJB2 testing, 119 patients (100 families)
No. of No of % of % of
patients families genetic total
Genetic 68 50 57.1
Non-syndromic 38 24 55.9
Dominant 1 1
Recessive 37 23
X-linked 0 0
Syndromic 18 14 26.5
Chromosomal 12 12 17.6
Acquired 22 21 18.5
Unknown 29 29 24.3
We proceeded to test all children in whom the cause of deafness was unknown, for 
mutations in the GJB2 gene (see Chapter 5 for more details). On analysing this same
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group of 119 patients (100 families), the distribution changed to that shown in Table 7, 
which does not change the overall distribution of the causes of deafness to a large degree.
Table 7: Causes of deafness after GJB2 testing: 119 patients (100 families)
No. of No of % of % of
patients families genetic total
Genetic 71 53 59.6
Non-syndromic 41 27 57.7
Dominant 1 1
Recessive 40 26
GJB2+ 20 14
X-l inked 0 0
Syndromic 18 14 25.3
Chromosomal 12 12 16.9
Acquired 22 21 18.5
Unknown 26 26 21.8
For the group as whole (119 patients/100 families) genetic causes appear to be the most 
common cause of deafness in the Bangladeshi population accounting for 59.6% of 
patients. Acquired causes were responsible for hearing loss in 18.5% patients and in 
21.8% cases the cause of deafness was undetermined. Of the deafness due to genetic 
causes, 57.7% were non-syndromic, 25.3% syndromic and 16.9% were chromosomal. 
Amongst the 12 children who had hearing loss due to chromosomal causes, most (93.3%) 
of these children had Down syndrome and one child had Trisomy 8. In the 27 families 
with non-syndromic deafness nearly all patients (96.2%) had recessive deafness except 1 
family who had dominant deafness.
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4.1.2 Deafness associated with a syndrome
In the group with syndromic deafness (18 patients/14 families) the most common cause 
was an unknown syndrome in nearly one third of patients. These children had 
dysmorphic facies or other clinical features but no specific diagnosis could be assigned to 
them. The other syndromes associated with hearing loss found in this study are shown in 
Table 8. Consanguinity in the group of patients with an unknown syndrome was 100% 
(5/5 families). This reiterates the fact that rarer diseases manifest in highly 
consanguineous populations.
Table 8: Syndromic Children (18 patients, 14 families)
Cause No of children % of total patients
Branchia-Oto-Renal syndrome 2 1.6%
Pierre Robin Sequence 1 0.8%
Unknown syndrome 5 4.2%
Pendred syndrome 2 1.6%
Waardenburg syndrome 2 1.6%
Walker Warburg Syndrome 1 0.8%
Usher syndrome 1 0.8%
Stickler syndrome 1 0.8%
Peroxisomal disorder 2 1.6%
Metabolic disorder 1 0.8%
4.1.3 Deafness due to environmental causes
Amongst the group with deafness due to acquired, environmental or other causes (22 
patients/21 families), the hearing loss was associated with factors due to prematurity in 
nearly one third of the patients. Overall amongst the total study group prematurity was 
associated in about 6 percent of all patients. In these patients with prematurity other 
factors may have contributed to the hearing loss. Two of these patients also had
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associated jaundice and one had intracranial haemorrhage. The other causes in this group 
were cerebral palsy/hypoxia, CMV, otosclerosis, otitis media, meningitis, 
aminoglycoside toxicity, hypoxia at birth and infective polyneuropathy (Table 9).
Table 9: Acquired/Environmental causes (22 patients/21 families)
Cause
Hypoxic-ishemia
Prematurity
No of children % of total % of environmental causes
Aminoglycoside toxicity 1
Infective polyneuropathy 1
CMV
?Otosclerosis* 
Otitis media** 
Meningitis
6 5.1% 27.3%
7 5.9% 31.8%
1 0.8% 4.5%
1 0.8% 4.5%
2 1.7% 9.1%
3 2.5% 13.6%
 0.8% 4.5%
 0.8% 4.5%
*This patient had a family history o f  otosclerosis and ? had cochlear otosclerosis. 
**T h is  patient developed sensorineural deafness due to long-standing otitis media
4.1.4 Severity of hearing loss
Severity of deafness was calculated from the most recent audiogram as an average of 
hearing at frequencies 500, 1000, 2000 and 4000 Hz in the better hearing ear. The 
severity was classified as mild (20-39 dB), moderate (40-69 dB), severe (70-94 dB) and 
profound (more than 95 dB). Of the 134 patients, all except 7 patients had symmetrical 
hearing loss. For the seven patients with asymmetric hearing loss, the severity was 
classified as for the better hearing ear. As per these criteria nearly 66.6% children had 
severe or profound deafness. The distribution in this group of Bangladeshi children as a 
whole was: profound deafness in 53 (39.5%), severe deafness in 35 (26.1%), moderate in 
46 (34.3%)(Table 10). Another 8 children had mild deafness and were not included in 
this study.
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Table 10: Severity of hearing loss
Severity of H Loss Whole group
Profound 39.5%
Severe 26.1%
Moderate 34.3%
4.1.5 Audiometric Shapes
The shape of the audiogram was noted for all the patients and recorded as described in 
the definitions section (page 12). Taking the whole group, the most common audiogram 
shape was flat in 77 of the 134 patients (57.4%). The other audiogram shapes were as per 
table 11.
Table 11: Shapes of audiogram: Total-134 patients
Shape of audiogram Number of patients Percent of total
Flat loss 77 (36-profound, 19-severe, 22-moderate) 57.4%
Low frequency ascending 12 (1-profound, 6-severe, 5-moderate) 8.9%
Mid frequency loss 11 (2-profound, 5-severe,4-moderate) 8.2%
Gently sloping 25 (14-profound, 4-severe, 7-moderate) 18.6%
Steeply sloping 9 (2-profound, 2-severe, 5-moderate) 6.7%
The subgroup with flat audiogram shape had all levels of severity of hearing loss, though 
most of the children had severe or profound deafness (36/77). Of the 77 children with flat 
audiogram shape, 36 had profound deafness, 19 had severe deafness, and 22 had 
moderate deafness.
In the subgroup with gently sloping audiogram, of the 25 children, 14 had profound 
deafness, 4 had severe deafness, 7 had moderate deafness. In the low frequency 
ascending subgroup, of the 12 children, 1 had profound deafness, 6 had severe and 5 had
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moderate hearing loss. In the 11 children with mid frequency hearing loss, 2 had 
profound loss, 5 had severe and 4 had moderate hearing loss. In the 9 children with 
steeply sloping hearing loss, 2 had profound, 2 severe, 5 moderate hearing loss.
4.1.6 Progression of hearing loss
The information on progression of hearing loss was collected by analysing the serial
audiograms in patient records. The hearing loss was classified as progressive if the 
average pure tone thresholds had worsened by more than or equal to 15dB within a 10 
year period.
Progression of deafness was confirmed on audiogram in 14 patients (10.9%) out of 128 
on whom this information was available. This number of children with progressive 
deafness may be an underestimate as for some children the deafness was confirmed at a 
later age and there were no previous records for these children to decide whether the 
hearing was stable or progressive.
It is noteworthy that the majority (10/14 [71.4%]) patients with progressive deafness had 
a genetic cause. The cause was acquired in 1/14 (7.14%) and unknown in 3/14 (21.4%) 
patients. None of the children with progressive deafness were positive for mutations in 
GJB2. In 13 of these 14 children (92.8%) the deafness had progressed to severe or 
profound deafness. In 5 of these children the parents were consanguineous.
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Table 12: Progressive hearing loss-14 patients 
Cause of deafness
Genetic 10
Non-syndromic 2
Recessive 2
Syndromic 6
Unknown syndrome 1
Pendred syndrome 1
Waardenburg syndrome 2
Peroxisomal disorder 1
? metabolic disorder 1
Chromosomal Trisomy 21 2
Acquired 1
Otitis media 1
Unknown 3
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4.2 Discussion
In this study group of Bangladeshi ethnic origin, the most common cause of hearing loss 
was genetic in 59.6% patients. Amongst the genetic causes, most of the children had non- 
syndromic deafness in 57.7% patients. Even after genetic analysis, the cause of deafness 
remains undetermined in 21.8% patients. As this study population originates from a 
confined geographic region (Sylhet), there might be some other unknown genes 
responsible for these cases of deafness of undetermined aetiology.
Mutations in the GJB2 gene were found to be the cause of deafness in nearly one third of 
Bangladeshi children with non-syndromic deafness. This has a major implication for the 
investigation of deaf children of Bangladeshi ethnic origin. If GJB2 analysis is the first 
test done for investigation of deafness, it is likely to be positive in one in three 
Bangladeshi children, obviating the need for further investigation with potential saving of 
NHS resources.
Amongst the children in this study group with syndromes, most had an undiagnosed (ie 
undefined) syndrome. In this subgroup o f ‘unknown’ syndrome, all five families reported 
parental consanguinity. The high level of consanguinity in this group is not surprising 
since it is well documented that consanguinity reveals rare recessive disorders (Morton 
1991).
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For children with environmental causes of deafness, perinatal factors were found to be 
the most common cause of hearing loss in this population. The common perinatal causes 
were prematurity and perinatal hypoxia.
Interestingly, the proportions of deafness due to genetic, acquired and unknown causes do 
not differ significantly from proportions described in other populations, which supports 
the conclusion that deafness due to all causes may be increased in this population of 
Bangladeshi ethnic origin.
On distributing the whole study group as per their hearing loss, it was found that the 
patients were quite evenly distributed in all the categories of hearing loss i.e. moderate, 
severe and profound.
Hearing loss can be classified according to the audiogram shape (Liu & Xu 1994,Parving 
& Newton 1995). Some generalisations have been made according to the shape of the 
audiogram. It has been found that autosomal dominant inheritance was strongly 
associated with sloping audiogram profile (Liu & Xu 1994,Gorlin et al. 1995,Martini et 
al. 1996). Usually profound early onset hearing loss has recessive inheritance (Martini et 
al. 1996). Genetic hearing impairment is generally symmetrical. Hearing loss inherited 
recessively is usually profound and present at an early age, whereas dominant losses are 
less severe but progressive (Fraser 1976).
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In this study group, more than half of the patients had flat shaped audiograms. The next 
biggest group was patients with sloping audiogram (high frequency loss) in nearly a 
quarter of patients.
In this study group progression of deafness was confirmed on audiogram in nearly 11% 
patients. This may be an underestimate as for some of the patients the deafness was 
confirmed at a later age and there were no previous records for these children to decide 
whether the hearing was stable or progressive. On analysing these children further, it was 
found that for more than 70% of these children the underlying cause of deafness was 
genetic, of which more than half had a syndromic cause of deafness.
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5 GJB2 Testing
5.1 R esults
All children with non-syndromic deafness (67 patients/53 families) were seen by the 
author in the research clinic and consented for testing for mutations in the GJB2 gene. 
The Regional Clinical Molecular Genetics Laboratory at Great Ormond Street Hospital 
and the Institute of Child Health screened for mutations in the coding region, splice site 
mutations and the 342kb deletion in all the patients recruited for this study. Results are 
summarised in Table 13.
Of the 67 patients, 20 were confirmed to have biallelic pathogenic mutations in GJB2 
(29.8%)
Table 13: Results of 67 patients (53 families) with non-syndromic deafness 
GJB2 results Number of patients Number of families Percentage of patients
GJB2 positive 20 14 29.8%
GJB2 negative 47 39 70.2%
Of these 53 families, 23 families had recessive deafness diagnosed by pedigree analysis 
alone i.e. either the parents were consanguineous or there were siblings with deafness. 
Amongst these 23 recessive families, 8 (34.7%) were positive for GJB2 mutations.
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5.1.1 GJB2 mutations
The mutations and genotypes found in this study group are detailed in Table 14.
Table 14: Mutations in GJB2
Mutations Number of families!patients) Consanguinity in families
W24X/W24X 6(8) 4/6
IVS1+1/IVS1+1 1(3) 1/1
M1V/M1V 1(2) 1/1
V95M/V95M 1(1) 1/1
W77X/W77X 1(1) 0/1
M1V/V95M 1(1) 0/1
W24X/IVS1+1 2(3) 0/2
Q124X/IVS1+1 1(1) 0/1
Of these 20 probands, 15 (75%) were homozygous for pathogenic mutations and 5 (25%) 
were compound heterozygote. The parents of these children with mutations in GJB2 were 
known to be consanguineous in 7 families (50%). One of the patients not included in the 
above table was a heterozygote for W24X. It is difficult to say whether she has a missed 
second mutation or she is a carrier for W24X and her cause of deafness is acquired (as 
per history available she had ?meningitis in Bangladesh at the age of 3 years). She has 
been discussed in detail separately in Chapter 6.
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The mutation W24X was found to be the most prevalent mutation in this group 
accounting for 40% of all mutations. An example of a heterozygote for this mutation is 
shown below (Figure 14).
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Figure 14: Sequence data for W24X heterozygote, Top trace = normal control, 
Bottom trace = mutant G>A. Mutation of a G to an A changes the codon for 
Tryptophan (W) to a stop codon (X).
Polymorphisms in this study are shown in table 15.
Table 15: Polymorphisms seen in the study group (N-Normal sequence)
Mutation of GJB2 Number of patients
R127H/N 10
V1531/N ■ ■ ■ ■ 4
V271/N 3
E114G/N 2
c.15G>A/N 1
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5.1.1.1 Severity of hearing loss in the GJB2 positive patients
The severity of hearing loss in each patient is tabulated in Table 16 below. There are two 
cases (Family 2 & 9) of discordance of severity between siblings with same genotype. Of 
the 20 patients from 14 families, 9 patients (45%) had profound deafness, 4 (20%) had 
severe deafness and the rest 7 (35%) had moderate deafness.
Table 16: Severity of hearing loss in GJB2 positive patients
Family Patients Mutation Severity of Shape of
number Hearing loss Audiogram
1 1 W24X/W24X Profound Flat
2 W24X/W24X Profound Flat
2 3 IVS1+1/IVS1+1 Moderate Flat
4 IVS1+1/IVS1+1 Moderate Gently sloping
5 IVS1+1/IVS1+1 Profound* Flat
3 6 W24X/W24X Moderate* Flat
4 7 W24X/IVS1+1 Moderate Flat
5 8 M1V/M1V Profound Flat
9 M1V/M1V Profound Flat
6 10 W77X/W77X Profound Flat
7 11 W24X/W24X Severe Flat
8 12 W24X/W24X Profound Flat
9 13 W24X/W24X Profound Flat
14 W24X/W24X Severe Flat
10 15 M1V/V95M Severe Flat
11 16 V95M/V95M Profound* Flat
12 17 W24X/IVS1+1 Moderate Flat
18 W24X/IVS1+1 Moderate Flat
13 19 W24X/W24X Severe Flat
14 20 Q124X/IVS1+1 Moderate Flat
* These patients severity o f deafness is in contrast to what is expected o f  the genotype
5.1.1.2 Carriers of GJB2 mutations
The heterozygote carrier rates of GJB2 mutations, W24X and W77X were assessed in the 
Bangladeshi population. Control samples from anonymized Bangladeshi subjects, 
collected for a prevalence study on eczema, were used for analysis. These DNA samples 
were a kind gift from Prof David Kelsell and the analysis was performed by Ms Kerra
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Pearce at the Clinical Molecular Genetics Unit at the Institute of Child Health. Carrier 
rates amongst these unrelated Bangladeshi controls were 2/83 heterozygous for W24X 
and 1/63 heterozygous for W77X. No homozygotes were detected.
Given the carrier rate for W24X (2/83) in the normal Bangladeshi population, we would 
expect to find 0.145/1000 children with deafness due to homozygous W24X (2/83 X 2/83 
X V4). In this group of 25,809 children we would expect to find 3.7 children with 
homozygous W24X deafness, if there was no consanguinity. In this study we have found 
that if we exclude the families with consanguinity, 3 children were W24X homozygous 
for W24X mutations as expected.
5.1.1.3 Severity of hearing loss and GJB2 mutations (Genotype/Phenotype 
correlation)
In order to examine genotype/phenotype correlations, mutations were classified as 
Inactivating or Non-inactivating (Cryns et al. 2004). Mutations which are predicted to 
severely affect/stop the protein synthesis i.e. W24X, Ml V, W77X and Q124X have been 
classified as Inactivating mutations (I) and those potentially allowing synthesis of some 
protein i.e. IVS1+1 and V95M have been classified as Non-inactivating mutations (N). In 
the case of the Ml V mutation Methionine is replaced by Valine at position 1. Being the 
initiating codon, protein synthesis is likely to be severely affected. Figure 15 shows the 
relationship between mutations in GJB2 with the severity of hearing loss. Generally it 
was found that patients who were homozygous for the inactivating mutations (I/I) had 
severe or profound deafness. Those patients who were compound heterozygote for the 
mutations (N/I) had moderate hearing loss with the exception of one patient who had 
severe loss.
8 8
o 4
■ a 1 J
I/I
I Profound 
I Severe 
□ Moderate
N/l
Mutations
N/N
Figure 15: Distribution of severity of hearing loss & GJB2 mutations
To analyse this further these patients are sub-grouped according to the severity of their 
hearing loss. Of the 9 patients positive for GJB2 mutations with profound hearing loss, 7 
had protein truncating mutations. Of these 4 were homozygous for W24X and 1 
homozygous for W77X, both mutations likely to result in no Connexin 26 protein being 
synthesized. Another 2 patients were homozygous for the mutation Ml V. One patient in 
this subgroup was homozygous for the splice site mutation IVS1+1, which is assumed to 
result in reduced protein being formed because of the faulty splicing of the mRNA. One 
patient was homozygous for the mutation V95M.
Four patients with GJB2 mutations had severe deafness. Three of them were homozygous 
for the W24X mutation and one was compound heterozygous for Ml V/V95M mutations.
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Seven patients with GJB2 mutations had moderate deafness. Two of the patients were 
homozygote for splice site mutation IVS1+1. One patient was homozygous for W24X, 
three were heterozygous for W24X and IVS1+1 and one for Q124X and IVS1+1.
5.1.1.4 Audiometric shape of GJB2 positive patients
Of the 20 patients who had GJB2 mutations (Figure 16), 19 (95%) had flat shaped 
audiogram and 1 had gently sloping audiogram (mutation IVS1+1/IVS1+1). There was
no U shaped or steeply sloping audiograms in this group.
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Figure 16: Audiogram shapes in GJB2 positive patients (Red-Right ear; Blue-Left
ear)
5.1.2 GJB2 negative
Of the 67 patients (53 families) tested for GJB2 mutations, 47 patients belonging to 39 
families were negative for mutations in the GJB2 gene. All these patients were tested for 
mutations in exon2, the splice site mutation (I VS 1+1) and de!342kb.
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5.1.2.1 Severity of hearing loss in GJB2 negative patients
Of these 47 patients in this group, it was found that 19 had profound deafness, 15 severe 
and 13 had moderate hearing loss. Of these 5/47 had progressive deafness on serial 
audiograms.
Table 17: Severity of hearing loss in GJB2 negative patients
Severity of hearing loss Number of patients Percentage
Profound deafness 19 40.4%
Severe deafness 15 31.9%
Moderate deafness 13 27.6%
5.1.2.2 Shape of audiograms in GJB2 negative
The audiogram shapes in this subgroup of 47 patients was quite mixed. Half of these 47 
patients had flat audiograms (Figure 17). The remainder of the patients had a mixture of 
audiogram shapes as shown in Table 18 and Figures 18, 19 & 20. The second most 
common shape of audiogram in a quarter of patients was the gently sloping audiogram. 
Mid frequency hearing loss i.e. cookie bite shaped audiogram was seen in 12.7% patients.
Table 18: Shape of audiograms in GJB2 negative
Shape of audiogram Number of patients Percentage
Flat 23 48.9%
Low frequency ascending 5 10.6%
Gently sloping 13 27.6%
Mid frequency loss 6 12.7%
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Figure 17: Flat shape Audiograms of Connexin negative patients (Red-Right ear; 
Blue-Left ear)
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Figure 18: Gently sloping shape audiograms of Connexin negative patients (Red- 
Right ear; Blue-Left ear)
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Figure 19: Mid frequency loss shape audiograms of Connexin negative patients 
(Red-Right ear; Blue-Left ear)
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Figure 20: Low frequency ascending shape audiograms of Connexin negative 
patients (Red-Right ear; Blue-Left ear)
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5.1.3 Comparisons of hearing loss in GJB2 positive & negative patients
The patients who were positive for mutations in the GJB2 gene and those negative for 
these mutation were compared with respect to their clinical hearing loss.
5.1.3.1 Severity of hearing loss in GJB2 positive & negative patients
Severity of hearing impairment and GJB2 status is shown in Table 19. Of the 20 patients 
who were positive for mutations in GJB2, 9 patients (45%) had profound deafness, 4 
(20%) had severe deafness and the rest 7 (35%) had moderate deafness. Of the remaining 
47 patients who were negative for mutations in GJB2, it was found that 19 (40.4%) had 
profound deafness, 15 (31.9%) severe and 13 (27.6%) had moderate hearing loss. On 
comparing these groups with different severity and the GJB2 mutation status, the 
difference between them was not significant though the numbers are small.
Table 19: Comparison of severity in GJB2 positive & GJB2 negative 
Severity of H Loss GJB2 positive GJB2 negative Difference
Profound 45% 40.4% 0.6>p>0.8
(95% Cl: -21.3,30.5) 
Severe 20% 31.9% 0.4>p>0.2
(95% CT:-10.1, 33.9) 
Moderate 35% 27.6% 0.6>p>0.4
(95% C l:-17.1,31.9)
5.1.3.2 Shape of audiogram and GJB2 positive & negative
In the patients positive for GJB2 mutations 19 out of the 20 patients had a flat audiogram 
and 1 had gently sloping audiogram. On the other hand in the GJB2 negative group 
though nearly half the patients had flat audiogram, the audiogram shapes were quite 
varied in that group. This is not unexpected as the cause of deafness in the GJB2 negative 
could be quite heterogeneous due to a wide variety of unknown mutations.
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5.2 Discussion
In this part of the study, in which Bangladeshi patients with non-syndromic deafness of 
unknown cause were screened for mutations in GJB2, 29.8% (20/67) were found to have 
bi-allelic pathogenic mutations. In other words, nearly every one in every three 
Bangladeshi children with non-syndromic hearing loss, with environmental causes 
excluded on history, would test positive for GJB2.
Although the most common mutation found in this study group of Bangladeshi ethnic 
origin was W24X in 55% patients (total-11/20; 8-homozygous, 3-compound 
heterozygous), there is significant mutational heterogeneity, in spite of the fact that all 
patients originate from the same Bangladeshi province of Sylhet. The mutations M1V, 
W77X, V95M, I VS 1 + 1 and Q124X have all been observed more than once in both 
homozygous and compound heterozygous form, reflecting the fact that the carriers of 
each are present in the population. We have been able to show a carriage rate of 2 in 83 
individuals for W24X and 1 in 63 for W77X. Thus consanguinity will lead to 
homozygosity for these mutations, and random matings between unrelated carriers, 
present in this population at significant levels, will lead to compound heterozygosity. In 
this study the consanguinity amongst these GJB2 positive families was very high (50%) 
which is why many families are homozygous for GJB2 mutations.
The overall carrier frequency in this population approaches the high figures seen in some 
other populations. The carrier frequency of 167delT in Ashkenazi Jews is approximately
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4% (Cohn & Kelley 1999) and a large study of the frequency of the 35delG mutation in 
3270 random controls from 17 European countries, estimates a carrier rate of this 
mutation of 1 in 35 (2.8%) for Southern Europe and 1 in 79 (1.2%) in central and 
northern Europe.
The mutational spectrum in this British Bangladeshi population is obviously different to 
the Caucasian British population, a fact which is not just interesting, but which also has 
diagnostic implications. For example, 6 patients (3-homozygous and 3 compound 
heterozygous) were positive for the splice site mutation, IVS1 + 1, which is outside the 
coding region of the gene. Diagnostic laboratories therefore need to be aware that this is a 
relatively prevalent mutation in Bangladeshi people and that it needs to be excluded in 
those with a single coding GJB2 mutation or those who are negative for coding region 
mutations, since it does not form part of the diagnostic protocol in many laboratories.
GJB2 is now acknowledged to be the commonest cause of genetic deafness worldwide 
with different ethnic groups having different prevalent mutations. In populations with 
European ancestry, the 35delG mutation, which causes severe to profound hearing loss 
accounts for approximately 75% of all mutated alleles (Estivill et al. 1998,Gasparini et al. 
2000, Van Laer et al. 2001), (Green et al. 1999,Cohn et al. 1999,Cryns et al. 2004). In 
non-Caucasians, 35delG is found rarely. In Ashkenazi Jews the 167delT mutation is the 
most commonly identified mutation (Morell et al. 1998), 235delC is most prevalent in 
Japanese (Abe et al. 2000) and R143W is the most common mutation in Ghana (Brobby 
et al. 1998). We found none of these mutations, not even the 35delG mutation, in the
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Bangladeshi children. Neither did we find the 342kb deletion upstream of the GJB2 gene, 
which is frequently present in patients who only have a single GJB2 mutation (Lerer et 
al. 2001,Castillo et al. 2002) and is the second most frequent mutation causing deafness 
in the Spanish population (Castillo et al. 2002). This deletion disrupts GJB6 (which is 
close by and encodes for Connexin 30) but leaves GJB2 intact but may alter the 
expression of GJB2 by deleting an upstream regulatory element.
Previous reports have examined GJB2 mutations found in families who originate from 
the Indian subcontinent. Three mutations W24X, W77X and Q124X have been found to 
be common in individuals from different parts of Indian subcontinent. Rickard et al in 
their study of 51 multi ethnic deaf patients from London, found 1 patient of Pakistani 
origin and 1 patient of Bangladeshi origin homozygous for W77X, 1 Indian patient 
homozygous for Q124X and 2 Indian sibs were heterozygous for W24X (Rickard et al.
2001). Scott et al studied six families of which four were Indian in origin (Scott et al. 
1998). Of these four families mutations in GJB2 gene were found in three families. One 
consanguineous family had three individuals homozygous for mutation Q124X; the 
second family (non-consanguineous) had two individuals homozygous for W24X and the 
third family (non-consanguineous) had four individuals who were compound 
heterozygote for W77X and W24X mutations in the GJB2 gene.
More recently in a larger study, Ghosh et al in their study of 320 consanguineous Indian 
families with deafness, found the overall incidence of GJB2 mutations to be 22.5%, 
which is close to the incidence of 29.8% in Bangladeshi families in this study (Ghosh et 
al. 2004). They also found W24X to be the most common mutation in these families and
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also found W77X, Q124X and Ml V which are also quite similar to the mutations in our 
Bangladeshi families. However unlike our study, they found 35delG mutation in 5 
families. In another study 35delG was also found in compound heterozygosity with 
W24X twice among 45 Indian families with non-syndromic deafness along with 4 
families who were homozygous for W24X (Maheshwari et al. 2003).
Interestingly, the W24X mutation has also been found at high prevalence in populations 
who are not obviously from the Indian subcontinent but who may have ancesteral links 
there, such as Romany gypsies from Slovenia and Spain, as well as Northern Eastern 
Hungarians (Alvarez et al. 2005).
5.2.1.1 Phenotype in GJB2
In this study, patients with GJB2 mutations presented with all degrees of severity of 
deafness from moderate to profound (profound-45%, severe-20%, moderate-35%) and 
this did not differ significantly from those in whom no mutations were found. In other 
words patients with any degree of hearing loss can have mutations in the GJB2 gene and 
thus all children with deafness of unknown aetiology could have GJB2 associated 
deafness, and should be offered genetic testing. Similar results have been reported by 
other authors (Cohn et al. 1999). Cohn et al studied 46 patients with GJB2 mutations 
35delG/35delG, 167delT/167delT and compound heterozygotes. The severity of hearing 
loss in these patients was profound in 65.2%, severe in 23.9% and moderate in 10.8% 
patients. In addition we also noted significant intrafamilial variability in severity of 
deafness, especially in the family with the IVS1 + 1/IVS1+1 mutation where one sibling
9 8
had profound deafness and other two had moderate hearing loss. Similar families have 
also been noted by others (Mueller et al. 1999).
The deafness caused by GJB2 mutations is usually prelingual and congenital, but it is 
possible that hearing is normal at birth and progresses rapidly during the first few months 
of life (Green et al. 2000). This would mean that although most of the children with 
GJB2 deafness will be identified as a part of the newborn screening, some children who 
have GJB2 mutations may pass the newborn screening and become deaf during infancy.
In the later years, deafness caused by GJB2 mutations is usually stable but progression 
has been reported (Denoyelle et al. 1999,Cohn et al. 1999). Cohn et al examined serial 
audiogram for 30 patients with GJB2 mutations and reported progression of hearing loss 
in 7 of these patients (4 homozygous for 35delG, 1 homozygous for 167delT and 2 
compound heterozygote) (Cohn et al. 1999). Two of 16 children with GJB2 mutations 
studied by Denoyelle et al over 10 years have showed progression. In our study there 
were no patients with GJB2 mutations who showed progression of deafness (Denoyelle et 
al. 1999). Similarly none of the 12 patients in the study by Wilcox et al showed 
progression (Wilcox et al. 2000) and Mueller et al did not report any progression in the 
serial audiograms of 24 patients with GJB2 mutations (Mueller et al. 1999). Perhaps a 
reason for this is small sample sizes in some studies (ours included), insufficient follow- 
up time or data, or difference between the mutations studied in the different publications.
Analysis of the audiograms of the patients in this study showed that most of the patients 
positive for GJB2 mutations had flat audiograms while those negative for the mutations
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in GJB2 had quite varied audiogram shapes. This information may be useful clinically in 
cases where an individual has been found to be a heterozygote for a GJB2 mutation 
without a second mutation having been found. In these cases, it is not possible to tell 
whether the patient happens to be a carrier by chance, a finding which is unconnected 
with the aetiology of their deafness, or whether they have a second mutation in the gene 
which cannot be found using available testing methods. If such a patient had an unusual 
audiogram (i.e. not flat) this may indicate that heterozygosity for GJB2 is not connected 
to their hearing loss.
5.2.1.2 Genotype Phenotype Correlation
The correlation between genotypes and phenotypes for GJB2 mutations has been 
assessed on a large scale within the last few years.
Cryns et al reported results of a multicentre study from Europe and United States 
involving 277 patients. They suggested that inactivating mutations, which include stop or 
frameshift mutations show significantly more severe hearing loss than those caused by 
non-inactivating mutations i.e. missense mutations (Cryns et al. 2004). We found a 
similar relation in our small group of patients. Most of the patients (8/9-88.9%) who were 
homozygous for protein truncating mutations i.e. W24X, W77X were found to have 
severe or profound hearing loss. Only one patient out of eight, homozygous for W24X 
had moderate deafness, although one patient homozygous for V95M had profound 
deafness, which is contrary to this theory. Two patients homozygous for the mutation 
Ml V at the initiating codon, were also found to have profound deafness, which is perhaps 
not surprising, since although this is a ‘missense’ change it is unlikely that any protein,
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Connexin 26, could be synthesized when the initiating codon is mutated. Similarly two 
patients homozygous for the splice site mutation, IVS1 + 1, had moderate deafness, which 
may be because splice mutations may often allow production of some normal mRNA 
thereby permitting some protein synthesis to occur. All patients except one (4/5-80%) 
with compound heterozygous mutations had moderate deafness (3-W24X/IVS1+1; 1- 
Q124/IVS1+1) and one had severe deafness (Ml V/V95M).
Another large multicentre study involving 1,531 patients from 16 countries by Snoeckx et 
al analysed GJB2 genotype and phenotype (audiometry) in patients with non-syndromic 
autosomal recessive hearing loss (Snoeckx et al. 2005). They identified 83 mutations in 
the study group and classified 47 as non-truncating mutations and 36 as truncating 
mutations. They reported that the degree of hearing loss associated with biallelic 
truncating mutations was significantly more severe than the hearing loss associated with 
biallelic non-truncating mutations such as M34T, V37I and L90P where hearing loss was 
mild to moderate deafness. On the other hand 35delG/R143W and 35delG/delGJB6 had 
significantly more severe deafness than 35delG/35delG.
From these studies it can be inferred that phenotypes caused by truncating GJB2 
mutations are more severe than those caused by missense mutations. Thus genotype is a 
fundamental factor in predicting phenotype. However, phenotype variations among the 
same genotypes exist, both within and between families. These variations may be due to 
factors such as alterations in promoter regions and additional genes(del Castillo et al.
2002), modifier genes(Abe et al. 2001) and environmental factors.
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Such correlations may help in predicting the mutation as per the severity of hearing loss 
i.e. someone with a profound hearing loss seen in the clinic can be assumed to be 
homozygous for an inactivating mutation. The clinician still has to wait for the final 
genetic analysis. These correlations may be also useful in predicting the likely course of 
hearing loss and may help in making decisions regarding management of the patient.
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6 Case Studies
6.1 C ase study num ber 44
Case number 44 is 14 years old at present. He developed Haemophilus meningitis at the 
age of 1 year, during which his parents suspected hearing loss. He was confirmed to be 
profoundly deaf and hearing aids were given. Over the last 8 years his deafness has 
progressed. He communicates by speech. There was nothing significant in the prenatal or 
perinatal history and developmentally he was normal. His parents are not 
consanguineous. There is no family history of deafness. His general physical and ENT 
examination were normal. On investigating, it was found that all his blood tests were 
normal. CT scan of temporal bones showed bilateral mildly dilated vestibular aqueducts 
and normal cochleae. Perchlorate scan appeared to show 22% discharge although the 
baseline was highly variable due to movement artefact. At this stage a diagnosis of 
Pendred syndrome was considered and he was referred for a second opinion to a 
professor of neuroendocrinology. In view of subtle dilated vestibular aqueducts, MRI was
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requested and also genetic analysis for Pendred mutations (the SLC26A4 gene) was 
requested.
The consensus opinion was that in view of the fact that there was a clear association 
between the apparent onset of hearing loss and the episode of meningitis, the more likely 
cause of deafness was meningitis. It was thought that the perchlorate discharge test may 
have been artefactual, while the vestibular aqueducts only showed minor changes. The 
MRI was reported to show normal endolymphatic sacs. In addition his Pendrin level 1, 2 
and 3 mutation analyses were negative. In view of these, the cause of his hearing loss was 
thought to be due to meningitis.
The interesting feature of this case was the difficulty in reaching a diagnosis/cause for the 
hearing loss. It is interesting how the diagnosis changes as the results of complex 
investigations unfold. The results of initial investigation pointed towards the diagnosis of 
Pendred syndrome, which became less likely as other results came through. After various 
expert opinions the cause of deafness was thought to be meningitis.
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6.2 Case studies number 109 & 118
i  o
118
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Case number 109 is nephew of case number 118 (her sister’s son). Case 109 is 5 years 
old at present. His parents suspected hearing loss when he was 9 months of age and was 
confirmed to have severe hearing impairment at 10 months of age, soon after which he 
was given bilateral hearing aids. He communicates mainly by British Sign Language. 
There was nothing significant in the prenatal or perinatal history and developmentally he 
was normal. His parents are not consanguineous and he is their only child. There was a 
family history of deafness i.e. his maternal aunt (Case 118). She was believed to have 
become deaf after a possible episode of meningitis in Bangladesh. His general physical 
and ENT examination were normal. On investigation, it was found that all his blood tests 
(Full blood count, urea & electrolytes, liver function tests, thyroid function tests) were
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normal. His CT scan, renal ultrasound and ECG were normal. On genetic analysis he was 
found to be homozygous for W24X mutations in the GJB2 gene.
His maternal aunt Case number 118 is 24 years old at present. Her hearing loss was 
confirmed at the age of 9 years. Parents associate the onset of hearing loss with an 
episode of fever with fits at the age of 4 years (? meningitis). The delay in diagnosis of 
her hearing loss was because she was living in Bangladesh before 9 years of age. MK 
communicates by speech and has very well developed language. She has profound 
hearing loss and her hearing loss has been stable over past 15 years. No significant 
factors were elucidated in her prenatal or perinatal history. Her parents are not 
consanguineous. She has four siblings, all of whom have normal hearing. The only family 
history of hearing loss is her nephew (case 109). Her general physical and ENT 
examination were unremarkable except for a left preauricular tag. All investigations were 
normal for her.
Her genetic testing revealed that she was heterozygous for the W24X mutation in GJB2. 
No second mutation to account for her hearing loss in GJB2 was found. This 
heterozygous status for W24X mutation could suggest that either she has another 
mutation in GJB2 which cannot be detected at present, or she is a carrier for W24X and 
the cause or her hearing loss is due to the illness in childhood. She is also negative for the 
A1555G mutation.
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This family is interesting as the nephew has prelingual profound hearing loss which is 
clearly due to homozygous W24X mutations. He mainly uses sign language with limited 
speech. It was assumed that his aunt’s deafness would also be genetic due to the same 
cause. However, delving further into her history together with investigations and the fact 
that she was postlingually deaf, suggested an environmental cause of deafness, supported 
by the finding that she was clearly a heterozygote for W24X. She is likely to be a carrier 
by chance.
6.3 C ase study num ber 54 & 64
54 64
Cases number 54 and 64 are siblings with hearing loss. Case 54 is at present 19 years old. 
She was suspected to have hearing loss at the age of 4 years. This was confirmed and she 
was subsequently given hearing aids. She has profound hearing loss which has been 
stable. She communicates by British Sign Language. There was nothing significant in her 
prenatal or perinatal history. Her parents are consanguineous. She has six siblings, of 
whom five have normal hearing and one has hearing loss (case 64). Her general physical 
and ENT examination were unremarkable. All investigations were normal except for her 
genetic testing which revealed that she was homozygous for the V95M mutation in GJB2.
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Case 64 is at present 14 years old. His hearing was checked at 2 months of age because of 
his sister’s hearing loss. He was confirmed to have hearing loss at 7 months of age and 
was subsequently fitted with hearing aids. He also has profound hearing loss which has 
been stable. He also communicates by British Sign Language. There was nothing 
significant in his prenatal or perinatal history. His general physical and ENT examination 
were unremarkable. All investigations were normal in him. His genetic testing did not 
reveal any mutations for GJB2, in particular he does not have the V95M mutation on 
either allele.
Siblings with similar hearing loss bom to consanguineous parents are expected to have 
the same mutations in the GJB2 gene. It is of interest that one of them is homozygous for 
the mutation and yet the other sibling does not show any evidence of the mutation. One 
possible explanation could be that there are two recessive genes causing deafness in this 
family. The V95M mutation in GJB2 could be one of them and we are not able to detect 
the other at present.
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7 General results
7.1.1 Languages used at home
Of the 53 families seen in the research clinic, in 11 families (20.8%) the parents could not 
read English or Bengali and could communicate only verbally in Sylhetti. These 11 
families were given audio tapes in Sylhetti as further information about the research. The 
parents in the other 42 families could read either English or Bengali and were given 
information leaflets in the language they preferred.
In all the 118 children on whom the information was available, Sylhetti was spoken at 
home. For 49 children the only language used at home was Sylhetti. In families of 39 
children English as well as Sylhetti was spoken at home. Sign language was being used at 
home for 30 children in addition to Sylhetti or English.
Table 20: Languages used at home
Languages used at home Number of patients Percentage
Sylhetti only 49 41.9%
Sylhetti & English 39 33.1%
Sylhetti & Sign language 23 19.5%
Sylhetti & English & Sign language 7 5.9%
Information on child’s first/preferred language was available for 118 patients (Table 21). 
It was found that for 30 children the first language was English and Sylhetti in 41 
patients. A significant number (47; 40.3%) used British Sign Language as their first
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language. As expected, children’s preferences of language do differ from those of their 
parents.
Table 21: Child’s first language
First Language
Sylhetti
English
British Sign language
Number of patients Percentage
41
30
47
34.7%
25.4%
39.8%
7.1.2 Mode of communication
Of the 120 children on whom this information was available, 59 communicated using 
speech, 16 communicated using gestures, 32 were exclusively British Sign language 
users and 13 children used a combination of speech and sign language.
Table 22: Mode of communication
Communication Numbers Percentage Severity of deafness
Speech alone 59 49.2% Profound-4, Severe-21, Moderate-34
Speech & Sign both 13 10.8% Profound-6, Severe-5, Moderate-2
Sign language only 32 26.7% Profound-32
Gestures 16 13.3% Profound-9,Severe-3, Moderate-4
Of these 48 sign language or gesture users, in 30 children’s families (62.5% of sign users)
sign language was also being used at home by the parents to communicate with the child.
Most of these parents who learnt sign language were young parents who were very keen
to be involved in their child’s overall development and education.
7.1.3 Initial suspicion of Hearing loss
Of the 119 patients, in the majority of the patients the hearing loss was first suspected by 
parents (59/119). In 34/119 hearing loss was suspected by child development team,
13/119 by school teachers, 9/119 by health visitors and 4 of these were picked up on the
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newborn hearing screening programme (Date of birth’s of these children were 4/7/03, 
27/10/03, 2/3/04, 15/5/04). In 15 patients this information was not available. Amongst 
this study group the neonatal hearing screening had been performed in only three patients 
but it is expected that in future most of the children with hearing loss will be detected at 
the neonatal hearing screening.
Table 23: Initial suspicion of hearing loss
Hearing loss- initial suspicion Number of patients Percentage
Parents 59 49.6%
Child development team 34 28.5%
Schoolteachers 13 10.9%
Health visitor 9 7.5%
Newborn hearing screening 4 3.4%
7.1.4 Age of confirmation of hearing loss
The average age of confirmation of hearing loss in this group of patients as a whole was 
at the age of 3 years 5 months (range-1 month to 15 year). On dividing these children as 
per the decade in which they were bom, it is quite apparent that with the passage of time 
(Table 24) the age of detection of deafness has fallen in this study group. This indicates 
that the audiology services have improved over the decades.
Table 24: Age of confirmation of hearing loss in different decades
Children Born in decade Mean age of Mode age of
confirmation of confirmation of
Hearing Loss hearing loss
1980-1989 4 years 5 months 3 years
1990-1999 3 years 1 month 2 years
2000 onwards 1 year 3 months Less than 6 mths
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7.1.5 Time between confirmation of diagnosis and hearing aids
This data was collected as per the patient records. The duration between the confirmation 
of hearing loss and patient actually receiving the hearing aids was recorded. This duration 
ranged from 2 weeks to 14 months. The average duration for 97 patients for whom this 
data was available was 8 weeks. Of these 97 patients, 75 patients (77.3%) received their 
hearing aids within 6 weeks and 51 (52.5%) within 4 weeks. In most of the other patients 
the delay in hearing aids was due to the parents not being keen for the child to wear 
hearing aids due to social reasons.
Table 27: Duration between diagnosis and hearing aid
Time between diagnosis & hearing aid Number of patients Percentage
Less than 4 weeks 51 52.5%
Less than 6 weeks 75 77.3%
More than 6 weeks 22 22.7%
7.1.6 Attitudes in this study group
7.1.6.1 Reason for participation in this research
Families who were seen in the research clinic were asked their reasons to participate in 
this research project. Of the 55 patients, 15 participated as they were interested to find the 
cause of their/their child’s hearing loss. Another 18 participated for the sake of their/their 
child’s future and the rest 22 participated both to find out the cause of deafness and for 
the sake of their own/their child’s future.
Table 28: Reason for participating in research: Total-55
Reason for participating in research Number of patients Percentage
To know cause of hearing loss 15 27.7%
For the sake of child’s future 18 32.7%
Both to know cause & child’s future 22 40.0%
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7.1.6.2 Completing the family
These 55 parents were also asked if a child with hearing impairment affected their 
decision about having other children. Of these 51 (92.7%) replied that a deaf child in the 
family did not affect their completing the family. Two parents replied yes and another 2 
did not comment. This was also evident from the fact that the hearing impaired child was 
not the youngest child in the family.
Table 29: Completing the family: Total-55
Effect of deaf child on having more children Number of families Percentage
No effect 51 92.7%
Effected completing family 2 3.6%
No comments 2 3.6%
7.1.6.3 Genetic Counselling
All these 55 patients/parents were asked if they would be interested in genetic 
counselling for planning their family or their child’s family in the future. Of these 39 
(70.9%) said yes to genetic counselling. Of the rest 4 (7.2%) were not sure, 6 (10.9%) 
answered that they were not planning any more children (did not want to comment) and 6 
(10.9%) said no to genetic counselling. Many of these parents went on to have further 
children maybe because they were not aware of the genetic factors. It may be that these 
parents wanted genetic counselling so as to understand the reasons for their child’s 
deafness.
Table 30: Views on genetic counselling: Total-55
Genetic counselling Number of patients Percentage
Interested 39 70.9%
Not interested 6 10.9%
Not sure 4 7.2%
No comments 6 10.9%
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7.1.6.4 Views on prenatal testing
The parents/patients were asked their views on prenatal testing to find out if the child 
could have hearing loss. They were explained in brief that chances of miscarriage during 
the testing were around 2%. More than half of the families (33/55, 60%) clearly answered 
that they were not interested in prenatal testing. 11/55 (20%) said they would be 
interested in prenatal testing if offered. 11/55 (20%) were not sure of their answer and
said they did not know what they would do in that situation.
Table 31: Views on prenatal testing: Total-55
Prenatal testing Number of patients Percentage
Not interested 33 60.0%
Interested 11 20.0%
Not sure 11 20.0%
Of the 11 patients/parents who showed interest in prenatal testing, because of the 
sensitivity of the issue, only three were asked if they would continue with the pregnancy 
if the child was found to be carrying deafness causing mutation. Of these only 1 answered 
that they would not continue with the pregnancy and the rest were not sure. Rest of the 9 
were not asked the question about continuing pregnancy, because of the sensitivity of the 
issue in this population and was advised by the liaison worker not to ask the question to 
these parents.
7.2 Discussion
7.2.1.1 Communication in this population
All the Bangladeshi families recruited for this study originate from Sylhet and Sylhetti is 
spoken in all the households as a preferred language at least by the parents. The Sylhetti
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language does not have a written script. Awareness of this before the project was started 
meant the information about the research was prepared as leaflets in English, Bengali and 
as audio tapes in Sylhetti. In this study it was found that parents could not read English or 
Bengali in one fifth of the families and they were given audio tapes in Sylhetti as 
information about research. This has health care and social implications far beyond this 
project as this may be the reason a large number of these families do not attend clinic 
appointments, leading to poor healthcare.
Sylhetti was spoken by all the families seen in this study. In the majority of families (~ 
42%) this was the only language spoken at home and these children with deafness would 
have to manage Sylhetti at home and learn English in school. For the rest of the families 
some other language was being used at home i.e. English or British sign language.
Another interesting finding was the child’s preferred or first language. It was not 
surprising that for only one third children (34.7%) the first language was Sylhetti. This 
can be explained by the fact that most of these children were the second generation in 
UK. For the remaining two thirds the first language was English (25.4%) or British sign 
language (39.8%).
The language barriers in this Bangladeshi community could be contributing to the high 
unemployment in this population. It has been reported that hearing impaired children 
from the ethnic minority communities had worse educational achievements as compared 
to their Caucasian peers (Cohne et a l 1990). It has also been reported that these children,
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for whom English is not the home language, are more socially isolated (Cohne et al.
1990). Another study reports that poor educational outcome and social isolation may be 
due to late diagnosis and inadequate rehabilitation (Webb 1996).
Children included in this study communicated using both verbal and non-verbal modes of 
communication. For the majority of children (approximately 40%) the only mode of 
communication was signing (British sign language or gestures if young). Of these 92% 
children had severe to profound deafness. Nearly 10% of children communicate using 
both speech and sign language. Of these about 85% children had severe to profound 
deafness. This seems to be the group of children who were aided and developed speech 
and have learnt both modes of communication and use either according to the need. The 
remaining 50% children use speech to communicate. Most of these children (-75%) have 
moderate to severe deafness. This has an implication on integration of these children into 
the wider community as those using only Sign language may feel isolated.
It was interesting to find out that amongst the children using signing at home; use of sign 
language was quite acceptable to most of the parents (-71%). This is quite commendable 
as anecdotally parents in this community do not like their children to wear hearing aids in 
public because of the social stigma attached to it. Another interesting finding was that a 
majority of the parents (-60%) of these children using sign language were actually using 
sign language to communicate with them at home. This is a reflection of the commitment 
of these parents to the children as they would have made special efforts to learn British 
sign language. Most of the parents in this study group were normal hearing.
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7.2.1.2 Diagnosis of Hearing loss
It is not surprising that in this study in the majority (50%) of the patients, the hearing loss 
was first suspected by the parents. The next biggest group was the initial suspicion of 
deafness by the child development team in nearly 30% children. In others the hearing loss 
was first picked up by the school teachers or the health visitors.
The Joint Committee on Infant Hearing endorsed Universal Newborn Hearing Screening 
in 2000 (Guilford et al. 2000). The aim was to provide hearing screening to all newborns 
before the age of 1 month, with confirmation of hearing loss in infants who do not pass 
the initial or a subsequent screening by the age of 3 months. Definitive treatment can then 
be started before the age of 6 months (Baroch 2003). The two main methods used in the 
screening are otoacoustic emission and automated auditory brainstem response. The 
limitation of the screening programme is that not all cases of childhood hearing loss will 
be detected. The neonatal screening may not identify children with progressive hearing 
loss, which is approximately 15% of preschool children with sensorineural hearing loss 
(Hone & Smith 2002). The main aim of the screening is to diagnose and manage early so 
that a child can develop normal language.
Before the early hearing detection programmes were implemented, the average age of 
detection of hearing loss was 1.5 to 3 years which is beyond the beginning of the critical 
interval for speech and language acquisition (Schrijver 2004). Delay in the diagnosis of 
hearing loss has an impact on development of language and communication skills and
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psychosocial development (Yoshinaga-Itano et al. 1998). It can also lead to isolation later 
in life (Baroch 2003).
The newborn hearing screening programme was started in these boroughs in 2000. In this 
study group four children were suspected to have hearing loss during the newborn 
screening. It is expected that in future more children will be picked up by the newborn 
screening. With the introduction of the newborn screening programme the average age of 
detection of deafness will go down substantially and will be helpful for these children in 
the long run.
The average age of confirmation of hearing loss in this study group was 3 years 5 
months. To analyse it further, the study group was divided into children bom in 1980s,
1990s and after 2000. It was observed that the age of confirmation has dropped down 
from 3 years in 1980s to 2 years in 1990s and further down to less than 6 months in 
children bom after 2000. This could be attributed to increased awareness on the part of 
parents or schools and improvement in health service provision.
Deafness should be diagnosed at an early age as early rehabilitation is important to 
provide better quality of life. Efforts have to be made to increase awareness amongst 
physicians and general public. Clear guidelines have to be established for evaluating 
children with deafness.
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Providing support to families through educational services, audiology services and social 
services help. It has been shown that earlier the child and the family get this support, 
more the benefit (Yoshinaga-Itano et al. 1998). The language development can be 
improved through the use of language support programmes and any residual hearing can 
be used through adequate amplification.
The time interval between the confirmation of hearing loss and the patient actually 
getting the hearing aid was recorded from the notes. Once the hearing loss has been 
diagnosed, the child should be rehabilitated as soon as possible in interest of child’s 
overall development. From the data collected in this study it was found that more than 
half of the children were aided within 4 weeks of confirmation of their hearing loss and 
nearly 78% within 6 weeks. Most of the patients who received the hearing aids later than 
this were because the parents were not initially keen for the children to use hearing aids.
7.2.1.3 Attitudes about hearing loss & genetic testing
The attitudes to genetic testing vary amongst the hearing and deaf patients (Middleton et 
al. 1998). Those patients seen in the clinic for this study were asked a few questions to 
assess their views about the research and genetic testing. It goes without saying that those 
parents who agreed to participate in the research were keen to find out the cause of their 
child’s hearing loss. All those who participated in the research were either just curious to 
know the cause of their child’s hearing loss or wanted to know the cause for the sake of 
their child’s future. Of course those parents who were not interested in the aetiology, 
declined to participate in the research.
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On looking at the family tree and asking the families it was quite clear that in more than 
90% of the families, a deaf child in the family did not effect their decision about having 
further children. On the other hand 4% patients did respond by saying that they felt 
apprehensive about having any further children after the birth of a deaf child. Another 4% 
did not want to comment.
Middleton et al found a predominantly negative view to genetic testing amongst delegates 
at the Deaf Nation conference in UK (Middleton et al. 1998). More than 50% of these 
delegates thought that genetic testing would do more harm than good. Another large 
survey from UK (644 deaf, 143 hard of hearing and 527 hearing subjects) revealed that 
culturally Deaf participants were significantly more likely to say that they would not be 
interested in prenatal testing for deafness (Middleton et al. 2001). Of the hearing subjects 
who would consider prenatal testing, 62-91% subjects would use this information to 
prepare themselves for the needs of the child. Only a small minority said they would have 
prenatal diagnosis to terminate the foetus.
Another study from US of hearing parents (96) of deaf children showed that most of the 
parents had a positive attitude towards genetic testing for deafness including prenatal 
testing, but none of them would use the information to terminate the pregnancy (Brunger 
et al. 2000a).
Another study of a mixed group of 337 subjects from US revealed that there was 
difference in the attitudes towards prenatal testing for hearing loss between culturally
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Deaf subjects and persons with hearing loss who are culturally associated with hearing 
community (Stem et al. 2002). Culturally Deaf subjects in this study felt that genetic 
testing for deafness will have negative effect on the Deaf community. Most of the 
culturally Deaf subjects were not keen on prenatal diagnosis for hearing loss as compared 
to those culturally associated with hearing community.
More recently general attitudes of hearing, hard of hearing and deaf population towards 
genetic testing for hearing loss were examined. It was found that 85% of hearing and 
62% of congenitally deaf or hard of hearing individuals would allow genetic testing for 
their child (Martinez et a l 2003). This indicates increasing acceptance of genetic testing 
for hearing loss.
7.2.1.4 Genetic Counselling
As a part of looking at the attitudes of parents in this study group, the parents were asked 
if they would be interested in coming to a genetic clinic for genetic counselling. More 
than 70% patients wanted to come for genetic counselling if invited. About 11% were not 
interested and 11% did not want to comment at that stage. The remaining 7% were not 
sure at that time.
Parker et al have reported about a survey on patients expectations from genetic services 
(Parker et al. 2000). Their study revealed that a sizeable number of families with deaf 
children were not being offered genetic services. Those families who had genetic 
counselling had positive and negative experiences in equal proportion. The families were 
primarily interested in the cause and risk of recurrence. A large number of those who
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were not offered genetic counselling would have liked to attend counselling. Also a large 
proportion of families who have had genetic counselling could not remember what 
recurrence risks were quoted. This could be minimised by summarising the session in a 
letter to the family and offering a follow up appointment.
7.2.1.5 Prenatal Diagnosis
Further on to the questioning about the attitudes, these parents were asked about their 
views on prenatal testing. Nearly 60% patients were quite clear that they were not 
interested in prenatal testing or diagnosis. Some of these themselves mentioned that they 
were not going to do anything about it, so there was no reasoning to unnecessarily take 
the risk of miscarriage. Another 20% said that they would be interested in the prenatal 
testing for deafness if offered and the rest 20% were not sure. In summary the majority of 
parents in this population of Bangladeshi ethnic origin were not keen on prenatal 
diagnosis.
The attitudes on prenatal testing of this Bangladeshi population in this study are quite in 
contrast to the study by Middleton on the same subject (Middleton et al. 2001). Prenatal 
diagnosis would be considered by 49% of hearing parents who have a deaf child and by 
21% of deaf parents. Within these groups, parents considering termination of pregnancy 
is a very small minority (Middleton et al. 2001).
Brunger et al surveyed normal hearing parents of deaf children in USA (Brunger et al. 
2000b). It was found that 96% parents had positive attitude towards genetic testing. Of
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these parents 87% were interested in prenatal testing for deafness. This is very different 
from our results and could be a reflection of ethnic background of parents in our study.
Another study was carried out by Ryan et al on 104 pregnant women attending Aberdeen 
maternity hospital (Ryan et al. 2003). They reported that 72% of the study group would 
want to know if they were carrier of a gene causing deafness and 74% would be 
interested in prenatal testing for deafness. Though amongst these only 7% would 
terminate an affected pregnancy.
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8 Discussion
This study of prevalence and causes of deafness in children of Bangladeshi origin 
resident in East London up to 16 years of age demonstrates at least 3.96 per 1000 are 
deaf, which is 2.4 times the national average of 1.65/1000. In the British Bangladeshi 
population our analysis suggests that consanguinity contributes to the raised prevalence 
of deafness. However removal of those children bom of consanguineous marriages from 
the calculation does not reduce the prevalence to the national figure and so it is likely 
therefore that environmental factors may also play a part in the high prevalence of 
deafness. Interestingly, the proportions of deafness due to genetic, acquired and unknown 
causes do not differ significantly from proportions described in other populations, which 
supports the conclusion that deafness due to all causes may be increased in this 
population.
Testing for mutations in the GJB2 gene in children with deafness, in whom 
environmental causes have been excluded by history, also reveals important information. 
Mutations in GJB2 have been shown to account for 34.6% of recessive deafness in the 
Bangladeshi population but the mutational spectrum is markedly different from that seen 
in the UK Caucasian population. As 1 in 3 non-syndromic hearing impaired Bangladeshi 
child is expected to have mutations in GJB2, all children with deafness of unknown cause 
should offered GJB2 testing regardless of the severity of hearing loss. High consanguinity
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and a high carrier rate for GJB2 mutations in Bangladeshi population also indicate that 
GJB2 mutations are common in this population.
In European populations the most common mutation in this gene is 35delG, which 
accounts for 70% of mutant alleles. Among Bangladeshi’s we did not find a single case 
of this mutation, but the commonest mutation was W24X, followed by IVS1 + 1, Ml V, 
V95M and W77X. This observation highlights the importance of documenting ethnicity 
when genetic testing is requested. Although East London is home to the highest 
concentration of Bangladeshi children there are many other regions in the UK where 
smaller numbers of Bangladeshi families have settled, and genetic laboratories may need 
to adapt their standard testing protocols in order to detect some of the common 
Bangladeshi mutations.
Most of the children with GJB2 mutations have hearing loss in the severe to profound 
category, a reflection of the commonest mutation, W24X, which is predicted to inactivate 
the gene. However the occurrence of the non-coding splice mutation IVS1 + 1, and the 
missense mutation V95M, associated with a milder hearing loss (Cryns et al. 2004), 
means that phenotype of hearing loss in this population cannot be used as a predictor of 
GJB2 mutation status. The children with GJB2 mutations in this study had a non- 
progressive hearing loss. The shape of the audiogram is an important finding. Non-flat 
shape of the audiogram can suggest that the GJB2 may not be the cause of deafness in 
that patient. Consanguinity is associated with rare syndromes and syndromic patients tend
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to have progressive hearing loss. It is important to keep these children on long term 
follow up for audiological assessments.
With the implementation of Newborn Hearing Screening the average age of diagnosis of 
deafhess from all causes is expected to reduce from 3 years 3 months in this study to less 
than 6 months. Given the demographics of this population, with a high proportion of 
young adults and a high fertility rate, we suggest that GJB2 testing is offered to all 
parents of deaf children very soon after diagnosis of deafhess. Many mothers become 
pregnant again whilst aetiological investigations are underway and genetic information 
will not only enable parents to make decisions about family planning but may help to 
guide health professionals in the management of the deaf child. In this study it was found 
that having a deaf child, does not appear to affect the decision of the families to have 
more children. So may be genetic counselling and testing will not make much difference 
to this community although parents may still want genetic counselling.
Finally, there remain significant numbers of children in whom the cause of deafness 
either remains unknown (usually singleton cases in their families) or the diagnosis is 
autosomal recessive deafness with no mutation in GJB2. There are 39 such families in 
our study, 29 of which have non-consanguineous parents. For rest of the 10 families with 
consanguineous parents, linkage mapping will be carried out in future to identify other 
genes.
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This suggests that there remain other genes responsible for childhood deafhess among 
Bangladeshi’s and that they may be present at a significant frequency in this population.
The population in Tower Hamlets is exceptional in contrast to regional and national 
trends. The majority of population is very young and expanding due to high fertility rate. 
This community has large families and a high proportion of genetic hearing loss. This 
suggests that genetic services are useful in this population. In dealing with this 
community it is important to be culturally sensitive and using the right language. The 
local services in the future should be planned keeping all this in view.
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9 Recommendations
• Connexin 26 testing should be done before requesting other aetiological 
investigations in non-syndromic deafness in children of Bangladeshi ethnic origin 
as mutations in GJB2 are the cause of deafhess in nearly one in three British 
Bangladeshi children with non-syndromic deafness.
• The spectrum of mutations in GJB2 is completely different to the Caucasian 
population which should be taken into account when genetic testing is requested.
• Genetic testing should be offered early to this population where consanguinity is 
common and birth rates are high, in order to provide genetic counselling for 
parents and to assist medical management.
• Since the prevalence of severe to profound congenital sensorineural hearing loss 
seems unusually high in this population, Tower Hamlets PCT and Hackney PCT 
would need to take this into account in their budgeting for cochlear implantation 
in their paediatric population
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10.3 Information Leaflets about Research
10.3.1 Information sheet for adults 
ADULT INFORMATION SHEET
GENETIC BASIS OF DEAFNESS IN EAST LONDON BANGLADESHI/ASIAN 
PEOPLE
AIMS
We want to find the causes of deafhess in children and young people in East London and 
to see how many people have inherited deafhess.
WHY IS THE STUDY BEING DONE?
In East London three times more children are bom with deafhess compared to other parts 
of the UK. In Tower Hamlets six times more Bangladeshi children have deafness than in 
Caucasian children. We don’t know why this is. It may be because deafhess is inherited 
in some families.
Some people have other relatives with deafness, so the cause of deafness in these people 
is very likely to be inherited. But most deaf people don’t have other family members who 
are deaf. However, research has shown that where the deafness is more severe and starts 
from birth, deafhess can still be inherited even when no one else in the family is deaf.
This is because the deaf person has inherited something from both their mother’s and 
their father’s side of the family i.e. have a double dose of a factor that causes deafness.
We want to find these factors which cause inherited deafhess in Bangladeshis.
HOW IS THE STUDY TO BE DONE?
To do this, we need to study as many deaf Bangladeshi/Asian individuals as possible in 
whom the cause of deafhess is not known and so we are asking for your help. We would 
like to know how many how many people there are in your family and who is deaf and 
who is hearing. We would like you and you parents to give a blood sample (and 
sometimes brothers and sisters as well even though they may be hearing so that we can 
compare what has been inherited from parents). We will only use your blood for deafness 
research and not for anything else.
If several people in your family are deaf we will ask if we can contact these relatives to 
help with the research and give a blood sample. Your relatives might prefer to have their 
blood taken by their GP if they live far away.
We also need information about the severity of your hearing loss and we will need to 
look at your medical notes to check results of blood & urine tests and X rays. You won’t 
need any extra tests other than normally done in an audiology or genetic clinic
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ARE THERE ANY RISKS AND DISCOMFORTS?
Having a blood sample taken may be slightly painful so we will use a special cream to 
numb the skin when we take a blood sample from you.
We understand that some people might not want to know that their deafhess is inherited. 
If you don’t want to know, please tell us, and we will not give you any results from the 
study. Your results will be kept confidential. We hope that as many families as possible 
will want to help us find out more about why so many Bangladeshis are deaf even if they 
don't want results for themselves.
WHAT ARE THE POTENTIAL BENEFITS?
This study will not cure your deafness.
If we can easily find out the cause of inherited deafhess in Bangladeshis, then in future 
when a Bangladeshi person/child is found to be deaf, he/she will not have to have as 
many tests to try and find the cause of deafhess (blood tests, urine tests and special 
scans). Also we hope that we would be able to give better information to you about 
severity of your deafness as you grow older. This information might also help the 
audiology team looking after you to choose the best treatment for that type of deafhess 
(eg hearing aid or cochlear implant or either).
WHO WILL HAVE ACCESS TO THE CASE RECORDS?
Only the research team working on the project and a person from the hospital whose job 
it is to make sure that the research is done properly (a member of the Research Ethics 
Committee).
WHAT ARE THE ARRANGEMENTS FOR COMPENSATION?
This project has been checked by the Health authority/Hospital and we do not think it is 
dangerous for you. However, if there is an unexpected problem we want you to know 
what you can do if any harm did come to you.
You could go to court to claim compensation. You would need to show that the problem 
happened because it was the hospital’s fault.
DO I HAVE TO TAKE PART IN THE STUDY?
No, not if you don’t want to. You will still have the same treatment in the clinic/hospital. 
WHO DO I SPEAK TO IF PROBLEMS ARISE?
If you have a complaint about this research, first, please talk to the researcher. If this does 
not help, please contact the Chairman of the Research Ethics Committee, by post at the 
Research and Development Office, Institute of Child Health,  
, or if urgent, by telephone on  and the office will arrange for 
you to talk to him.
RESEARCHER WHO WILL HAVE CONTACT WITH THE FAMILY
Mr. Yogesh Bajaj, Dr. Maria Bitner-Glindzicz, 
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DETAILS OF HOW TO CONTACT THE RESEARCHER
Mr. Yogesh Bajaj:  or Dr. Maria Bitner-Glindzicz:  
Or by post at Unit of Clinical and Molecular Genetics, Institute of Child Health,  
10.3.2 Information sheet for parents
PARENTS INFORMATION SHEET
GENETIC CAUSES OF DEAFNESS IN EAST LONDON BANGLADESHI/ASIAN 
CHILDREN
AIMS
We want to find the causes of deafhess in children and young people in East London and 
to see how many children have inherited deafhess.
WHY IS THE STUDY BEING DONE?
In East London 3 times more children are bom with deafhess compared to other parts of 
the UK. In Tower Hamlets six times more Bangladeshi children have deafness than 
Caucasian children. We don’t know why this is. It may be because deafhess is inherited 
in some families.
Some children have other relatives with deafhess, so the cause of deafness in these 
children is very likely to be inherited. But most deaf children don’t have other family 
members who are deaf. However, research has shown that where the deafhess is more 
severe and starts from birth, deafness can still be inherited even when no one else in the 
family is deaf. This is because the deaf child has inherited something from both their 
mother’s and their father’s side of the family i.e. have a double dose of a factor that 
causes deafness.
We want to find these factors which cause inherited deafness in Bangladeshi children. 
HOW IS THE STUDY TO BE DONE?
To do this, we need to study as many deaf Bangladeshi/Asian children as possible in 
w hom the cause of deafhess is not known and so we are asking for your help. We would 
like to know how many people there are in your family and who is deaf and who is 
hearing. We would like the deaf child and his/her parents to give a blood sample (and 
sometimes brothers and sisters as well even though they may be hearing so that we can 
compare what has been inherited from parents). We will only use the blood for deafness 
research and not anything else.
If several people in your family are deaf we will also ask if we can contact these relatives 
to help with the research and give a blood sample. Your relatives might prefer to have 
their blood taken by their GP if they live far away.
We also need information about the severity of your child’s deafness and we will need to 
look at their medical notes to check results of blood & urine tests and X-rays. Your child 
won’t need any extra tests other than those normally done in an audiology or genetic 
clinic
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ARE THERE ANY RISKS AND DISCOMFORTS?
Having a blood sample taken may be slightly painful so we will use a special cream to 
numb the skin when we take a blood sample from your child.
Some people might not want to know that their child’s deafhess is inherited. If you don’t 
want to know, please tell us, and we will not give you any results from the study. Your 
child’s results will be kept confidential. We hope that as many families as possible will 
want to help us find out more about why so many Bangladeshi children are deaf even if 
they don’t want results for themselves.
WHAT ARE THE POTENTIAL BENEFITS?
This study will not cure your child’s deafhess.
If we can easily identify which Bangladeshi children have inherited deafhess, then in 
future when a Bangladeshi child is found to be deaf, he/she won’t have to have as many 
tests to try and find the cause of deafhess (blood tests, urine tests and special scans). Also 
we hope that we would be able to give better information to parents about severity of 
their child’s deafness as the child gets older. This information might also help the 
audiology team looking after the child to choose the best treatment for that type of 
deafhess (eg hearing aid or cochlear implant or either)
WHO WILL HAVE ACCESS TO THE CASE RECORDS?
Only the research team working on the project and a person from the hospital whose job 
it is to make sure that the research is done properly (member of the Research Ethics 
Committee).
WHAT ARE THE ARRANGEMENTS FOR COMPENSATION?
The Health Authority/ Hospital has checked this project and we do not think it is 
dangerous for you or your child. However, if there is an unexpected problem we want 
you to know what you can do if any harm did come to your child.
You could go to court to claim compensation. You would need to show that the problem 
happened because it was the Hospital’s fault.
DO I HAVE TO TAKE PART IN THE STUDY?
No, not if you don’t want to. Your child will still have the same treatment in the 
clinic/hospital.
WHO DO I SPEAK TO IF PROBLEMS ARISE?
If you have a complaint about this research, first, please talk to the researcher. If this does 
not help, please contact the Chairman of the Research Ethics Committee, by post at the 
Research and Development Office, Institute of Child Health,  
, or if urgent, by telephone on  and the office will arrange for 
you to talk to him/her.
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RESEARCHER WHO WILL HAVE CONTACT WITH THE FAMILY
Mr. Yogesh Bajaj , Dr. Maria Bitner-Glindzicz, 
DETAILS OF HOW TO CONTACT THE RESEARCHER
Mr. Yogesh Bajaj: ,  or Dr. Maria Bitner-Glindzicz:  
Or by post at Unit of Clinical and Molecular Genetics, Institute of Child Health,  
10.3.3 Information sheet for children
Information for Children
We are asking you to help in a study to look for the causes of poor hearing in some 
children.
1. Aim of the study:
We would like to try and find out why some children have poor hearing.
2. Why is this study being done?
We do not know why some Bengali/Asian children have poor hearing. We want to try 
and work out why this happens.
3. How is this study being done?
When you come to the clinic you and your parents will be asked whether you would like 
to help with the study. If you want to help we will ask your parents about all the other 
people in your family and will ask you, your parents and your brothers and sisters to give 
a blood sample. Sometimes we might ask other family members to help us (an aunt, 
uncle, cousin or grandparents).
4. What are the dangers?
Having a blood sample taken is not at all dangerous but may be uncomfortable. If you 
wish we will use a cream which numbs the skin so that you will hardly feel anything.
5. Who will know about your help with this study?
Only the doctor involved in the study and your family doctor(GP). We do not put any 
extra information in the hospital notes.
6. What do we hope to find out?
We are trying to understand what causes some children to be bom with hearing loss but it 
may take us a long time. However, we hope that in the future we will understand more 
about the problem and this will be helpful to other children and their families.
7. Do you have to take part in the study?
No, you do not have to help with the study if you don’t want to, and nobody will mind.
8. If you are unhappy with the study, let your parents know as they have information 
on how to get in touch with us.
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10.3.4 Information sheet for General Practitioners
DEAFNESS IN EAST LO NDO N BENGALI PEOPLE
Genetic causes are responsible for a large proportion of deafness in childhood even where there is 
no one else in the family with deafness.
In East London three times as many children are bom with hearing problems, as 
compared to other parts of the UK. In Bengali children in Tower Hamlets six times as 
many children have hearing problems than in Caucasians. This may because genes 
causing deafness might be common in East London Asians, especially people whose 
families have come from Bangladesh. We think that the main cause of deafness in many 
children is due to some unknown gene, which is being passed down the generations. It 
probably causes deafhess only when two such genes are present in one individual one 
inherited from each parent. We are hoping to find that gene.
Although some people are known to have a family history of deafhess, many others know 
of no other relatives in their family who suffer from this problem. Nevertheless, research 
has shown that even where there is no family history, many cases have a genetic cause, 
particularly where the hearing loss is more severe and is of early onset in life and no other 
cause for the deafhess has been found.
We hope that if we can find out the gene causing deafhess in a child then the child will 
not have to go through all the other tests that are done to find the cause of deafness (blood 
tests, urine tests and special scans). Also if we know which genes can cause deafness in 
Bengalis/Asians we may be able to offer genetic testing of the commoner genes for 
families who request it (parents and relatives of deaf individuals).
In order to do this, we need to study as many deaf Bengali/Asian individuals as possible 
in whom the cause of deafhess is not known.
We need a blood sample to search for genes causing deafness.
For some families the gene responsible for their deafhess may be identified within the 
next few years and testing could be offered to other family members to see if they carry 
the gene.
DETAILS FOR FURTHER INFORMATION
Mr. Yogesh Bajaj:  
Dr. Maria Bitner-Glindzicz:  
Or by post at
Departments of Clinical and Molecular Genetics,
Institute of Child Health,
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10.3.5 Information leaflet for parents in Bengali
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10.3.6 Information leaflet for adults in Bengali
*rc>t»ni ^Uflkn4l/«flPMh Cvn w t5fif ?T ^!H »n C5RI? 1%%
«RT?1
I SJ I 2t>' i>4 Ucn)!Jli Adult IntormutKHi Sheet
140
10.4 Letters to patients and physicians
10.4.1 Invitation for Research
Subject: Research on causes of hearing loss in Bangladeshis/ Asians in East London.
Dear Sir/ Madam,
We are writing to you about deafhess in Bangladeshis/Asians in East London. The rate of 
deafhess in Bangladeshis is six times more than the national average. We are starting a 
research project to find out the cause for this.
I am writing this letter to invite you to join this research, to find the causes of deafness in 
Bangladeshis/ Asians in East London. Your help will mean giving us medical details 
about your child’s/your hearing loss and giving a blood sample.
If you want to find out more about this research, kindly give a ring to Dr Yogesh Bajaj on 
mobile  or at  
. If you want to help with the research kindly fill out the slip enclosed 
and send it back in the prepaid envelope.
I hope you will help us to find the reason for increased rate of deafhess in the community. 
Thanks.
Yours faithfully,
Mr Yogesh Bajaj, Dr M Bitner Glindzicz
Reply Slip 
Your Name: 
Address:
Telephone:
Would you prefer to be seen in the clinic at Donald Winnicot Centre or at your home:
Child’s Name:
Child’s Date of birth: 
Donald Winnicot Number: 
(if known)
Other hospital number:
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10.4.2 Invitation for Research in Bengali
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10.4.3 Appointment letter
Dear Sir/ Madam,
You have been given an appointment to see Dr Yogesh Bajaj, Registrar ENT, at on 
at the Donald Winnicot Centre, Coate Street, London. You will be seen in the audiology 
department at second floor. The appointment will last approximately 30-60 minutes. 
Kindly let the audiology department or know when you have arrived.
If you want to cancel your appointment, please call Dr Bajaj  
.
Thanks
Dr Yogesh Bajaj
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10.4.4 Letter to General Practitioner
Dear Doctor,
We are conducting a research to look for gene/s causing deafhess in East London 
Bangladeshi population. In East London three times more children are bom with deafhess 
compared to other parts of the UK. In Tower Hamlets six times more Bangladeshi 
children have deafness than in Caucasian children. We don’t know why this is? It may be 
because deafness is inherited in some families.
Your patient has kindly agreed to take part in our research into the genetic basis of 
deafhess.
We would like to take a detailed history and ask the patient and their parents to give a 
blood sample (and sometimes brothers and sisters as well even though they may be 
hearing).
If we can easily find out the cause of inherited deafness in Bangladeshis, then in future 
when a Bangladeshi person/child is found to be deaf, he/she will not have to have as 
many tests to try and find the cause of deafhess.
The research is being conducted under the guidance of Dr M Bitner Glindzicz, Consultant 
Genetics, Institute of Child Health. I enclose a copy of the patient information sheet for 
your records.
Yours faithfully,
Mr Y. Bajaj, MRCS, DLORCS 
Research Fellow ENT
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10.4.5 Letter of thanks to patients
Re: Bangladeshi children hearing loss project 
Dear Mr  & Mrs 
I am writing this letter to thank you for coming to the audiology clinic at Donald 
Winnicot Centre and agreeing to participate in the Bangladeshi children hearing loss 
project. I really appreciate your help which will be beneficial for the Bengali community 
and your child in the future. I will be writing to you in due course of time to inform you 
of our progress in this study.
Thanks once again.
Yours sincerely,
Dr Yogesh Bajaj 
Registrar ENT
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10.4.6 Letter to patients about results
Dear Mr & Mrs 
I am writing to you about our meeting at the Donald Winnicot Centre on 17/2/2004. As 
you would remember I had taken some blood from your child at that appointment. I have 
got results from that blood sample.
After genetic testing at Great Ormond Street hospital we have found that your child is 
positive for Connexin 26 gene. The most likely cause of deafhess in your child is due to a 
gene called “Connexin 26”.
You will be receiving a letter in the post from Dr M Bitner Glindzicz, Consultant 
Geneticist at Great Ormond Street Hospital inviting you to see her for genetic counselling 
and further advice.
If I can be of any further help, do not hesitate to contact me or  
.
Thanks
Yours sincerely,
Dr Yogesh Bajaj 
Research Fellow, ENT 
Great Ormond Street Hospital
Cc: 
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10.5 Data Collection Sheet
Hearing loss Research
Case Number:
Title:
Surname:
First Name:
DOB:
Age:
Hospital Number:
Father’s Name:
Mother’s Name:
Address:
Contact number:
G.P.:
Consultant:
School:
History
Present History
Duration of decreased hearing:
When was hearing loss first suspected?
How?
Did the child undergo neonatal hearing screening?
When confirmed?
Was there a delay in the diagnosis?
If yes, factors leading to the delay in diagnosis:
Has it changed/progressed?
Hearing Aids given:
Re, audio tape:
How does child/person communicate?
Is sign language used at home?
Is the sign language acceptable to parents?
Languages spoken at home:
Child’s first language:
Originally from:
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Severity of deafhess(Audiogram):
Date
Rt Lt Rt Lt Rt Lt Rt Lt
Hearing Level
Frequency Range
Audiogram Shape
Tympanogram
Date
Rt Lt Rt Lt Rt Lt Rt Lt
Hearing Level
Frequency Range
Audiogram Shape
Tympanogram
Progression of deafhess over time:
Does it fluctuate?
Ear discharge:
Tinnitus:
Vertigo:
Speech:
Any other ENT problems:
Any other current problems:
Diagnosis:
Cause of SN hearing loss in this patient:
How has this been ascertained: Clinical/molecular/lab test: 
Treatment planned:
Past History 
Antenatal History:
Viral illnesses in pregnancy:
Perinatal History:
Birth Weight:
Gestation of pregnancy:
Delivery:
Postnatal history:
Jaundice:
Meningitis:
Developmental History:
Age of head control:
Age of sitting:
Age of walking:
148
Any past medical problems:
Any past surgeries:
Family History 
Consanguinity:
Family history of deafhess: Siblings
Parents
Grand parents 
Cousins
Any other illnesses in the family:
Family Tree:
Attitude:
Are the child/ parents interested in knowing the cause of deafhess?
Why?
Did a deaf child in the family affect their completing the family?
If we found a gene causing deafhess in them/their child do they think other relatives will 
be interested in genetic testing?
Would they want genetic testing for family planning in future?
Views on prenatal testing considering the risk of miscarriage:
Would they continue with the pregnancy if child found deaf on prenatal testing: 
Examination
General Physical Examination:
Facial Features:
Ears:
External ear shape:
Pits/Tags:
External canal:
Tympanic membrane:
Nose:
Throat:
Neck:
Fistulae:
Goitre:
Any other abnormalities:
Investigations done: 
Patient/Child:
Blood Tests:
Radiology:
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Family hearing assessments:
Siblings:
Mother:
Father:
Grandmother:
Grandfather:
Other relatives:
Genetic mapping:
(Blood collected)
Patient/ Child:
Siblings:
Mother:
Father:
Grandmother:
Grandfather:
Other relatives:
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10.6 Census Data
2001 CENSUS TABLE S101 SEX AND AGE BY ETHNIC GROUP - 
HACKNEY
Table population: All people
Geographical level: England and Wales to Ward
ALL
PEOPLE
Asian or Asian British: 
Bangladeshi
ALL
00AM Hackney PEOPLE 202,820
00AM Hackney 0 to 4 16,752
00AM Hackney 5 to 7 8,466
00AM Hackney 8 to 9 5,700
00AM Hackney 10 to 14 14,082
00AM Hackney 15 2,430
00AM Hackney 16 to 17 5,282
this table have been randomly adjusted to avoid the release of
5,972
792
441
252
685
159
294
2001 CENSUS TABLE S101 SEX AND AGE BY ETHNIC GROUP - 
TOWER HAMLETS
Table population: All people
Geographical level: England and Wales to Ward
ALL
PEOPLE
00BG Tower ALL
Hamlets PEOPLE 196,100
00BG Tower Hamlets 0 to 4 15,177
00BG Tower Hamlets 5 to 7 8,137
00BG Tower Hamlets 8 to 9 5,228
00BG Tower Hamlets 10 to 14 13,708
00BG Tower Hamlets 15 2,640
00BG Tower Hamlets 16 to 17 5,413
Cells in this table have been randomly adjusted to avoid the release of
Asian or Asian British: 
Bangladeshi
65,553
8,739
4,915
2,957
8,032
1,525
3,154
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